• Author Index
• Abstract Index
• Subject Index
• Search
• Journal Homepage
• ISTH Homepage
• Online Journal
• Privacy Policy
• 2003
• 2005
• 2007
• 2009

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

S
Sørensen K. W.	-	Functional properties of recombinant factor Va mutated in a potential calcium-binding site
Sørensen K. W.	-	Changed inactivation pathway of factor Va by activated protein C in the presence of heparin
Sørensen B.	-	Development of inhibitors against factor VII in patient with severe factor VII deficiency
	-	Hemophilia patients and the assessment of thrombin generation in platelet-rich plasma and platelet-poor plasma
Sanchez-Luceros A.	-	Flow cytometry analysis of platelet activation throughout normal gestation and puerperium
Saayman A. G.	-	The efficacy of standard dose vs. 30 mL kg-1 FFP in correcting laboratory parameters of hemostasis in critically ill patients
Saba H.	-	Treatment of myelodysplastic syndrome with arsenic trioxide (ATO): response in refractory, transfusion-dependent patients
Saba N.	-	Sickle blood contains tissue factor positive microparticles derived from endothelial cells and monocytes
Saba H.	-	Relationship of thromboembolism (TE) to subsequent cancer diagnosis: a study in a veteran population
Sabater E. A.	-	Combined mechanical and pharmacologic thrombolysis for ilio-femoral deep venous thrombosis. Single center short-term outcomes
Sabater-Lleal M.	-	Factor VII plasma levels and the F7 structural gene: complete dissection of a human quantitative trait locus
Sabater-Lleal M.	-	Complexity of the genetic contribution to Factor VII deficiency in two Spanish families: clinical and biological implications
Sabatier F.	-	Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth retardation
Sabatini F.	-	Oral anticoagulation telemedicine management system: the MC-SAT project
Sabbion P.	-	The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study
Sabik K	-	The mannometric profile of native arteriovenous fistulas in the Avicenne Hemodialysis Center of Casablanca (preliminary results)
Sabin C.	-	Antithrombotic effects of selective P2Y1 and P2Y12 antagonists in anesthetized rats
Sabovic M.	-	Utility of in vitro closure time (PFA-100TM) for evaluating platelet related primary hemostasis in dialysis patients
Sabri S.	-	Cross-talk between alpha2beta1 integrin and GPVI receptors regulates actin polymerization through Rho GTPase and MAP kinase Erk1/2 signaling pathways in human megakaryocytes
Saccomando E.	-	A new Global Plasma Fibrinolytic Assay for the rapid analysis of hyper-/hypo-Fibrinolysis: relationship with blood lipids and inflammatory markers
Sachais B. S.	-	PF4 and heparin form high molecular weight complexes that is central to the pathogenesis of Heparin-Induced Thrombocytopenia
Sachais B.	-	A novel platelet-specific delivery system for fibrinolytic agents
Sachs U.	-	Human antibody against CD11b inhibits platelet–leukocyte interaction under high shear
Saci A.	-	Activation of pp125FAK by type 2B recombinant von Willebrand factor binding to platelet GPIb at high shear rate occurs independently of aIIb3 engagement
Sackel D.	-	Platelet microparticles carry CD40 ligand and up-regulate TF and VEGF in endothelial and melanoma cells: possible role in angiogenesis and metastasis
Sacks H. S.	-	Perioperative management of patients on oral anti-coagulants: a decision-analysis
Sadler J.E.	-	Type-2 mutations within the A1 domain of Von Willebrand Factor: how protein conformation modulates binding to platelet membrane GPIba
Sadler E.	-	ADAMTS13 structure and function
Sadler J. E.	-	Dominant negative anticoagulant effects of mouse recombinant meizothrombin precursor R157A/R268A delay thrombus formation in a mouse injured carotid artery
	-	Characterization of a mixed disulfide intermediate between the propeptide and the mature subunit of von Willebrand Factor during multimer formation
Saenko E. L.	-	Kinetics of factor X activation by membrane-bound complex of factor IXa and factor VIIIa
	-	Factor IXa/factor VIIIa-dependent pathway is responsible for the growth of clot away from the fibroblast monolayer surface
Saenko E.	-	LRP mediated catabolism of factor VIII
Safa O.	-	A new screening assay for abnormalities in the Protein C anticoagulant pathway
Safa O.	-	New chromogenic screening assay for detecting deficiencies in protein C and protein S
Safadi F. F.	-	Regulation of connective tissue growth factor (CTGF) in synovial lining and modulation of the disease course of acute arthritis in an experimental model of rheumatoid arthritis by residues D793-P824 derived from thrombospondin-1-type 3 repeats
	-	Connective tissue growth factor (CTGF) expression in synovial lining is down regulated by residues D793-P824 derived from thrombospondin-1 type-3 repeats (TSP1) in an experimental animal model of rheumatoid arthritis
Safaie R.	-	Rapid screening of factor IX mutations by SSCP and sequencing in 50 Iranian families
	-	Reporting presence of 9 novel mutations in hemophilia B patients in Iran
Saffaripour S.	-	Anti-thrombotic effects of tumor necrosis factor-a
Sage S. O.	-	Role of PI 3-kinase in glycoprotein VI-dependent calcium signaling in human platelets
Sage T.	-	A role for the thiol isomerase protein P5 in platelet function
	-	The inhibitory action of quercetin on GPVI-mediated platelet signaling and activation
Saggiorato G.	-	Pseudogene coamplification mimicking a 14-bp deletion mutation in exon 5 of plasminogen gene: a methodological study
	-	Anti-prothrombin antibodies in patients with recurrent venous thromboembolism
	-	Plasma fibrinolytic capacity and 4G/5G polymorphism of PAI-1 gene in heart and kidney transplant recipients with or without steroid immunosuppression
Sagrolikar A.	-	Development of economic and outcomes model of hemophilia treatment in Latin America and South-east Asia
Saha M.	-	Normal pregnancy is associated with decreased protein Z levels in the second and third trimesters compared to early pregnancy
	-	Patients with adverse pregnancy outcome have lower levels of protein Z and protein S compared to patients with normal pregnancy outcome
Sahni A.	-	Low intensity ultrasound increases endothelial cell nitric oxide synthase activity
	-	Molecular weight dependent heparin inhibition of endothelial cell stimulation by FGF-2 and VEGF
	-	Structural basis for differences in heparin-dependence of endothelial cell proliferative activities of human FGF-1 and FGF-2
Sahni A.	-	FGF-2 binds to fibrinogen fragment D1 and prevents degradation to fragment D2
	-	FGF-2 but not FGF-1 binds fibrin and supports long-term endothelial cell growth
Sahud M.	-	Glycoprotein IIb/IIIa complex is the target in mirtazapine-induced immune thrombocytopenia
Said S.	-	Ultrastructural changes in platelets after surgical manipulations in pigs liver
Saidova R. A.	-	Differential diagnostics of abnormal uterine bleeding
Sailer T.	-	Is inflammation involved in the development of thrombosis in patients with the lupus anticoagulant?
Sailer T.	-	IgG-antibodies (IgG-Ab) against beta-2-glycoprotein I (b2-GPI) are associated with an increased risk for thrombotic events (TE) in patients (pts) with the lupus anticoagulant (LA)
Sainte-Marie M.	-	Thrombolysis induced by streptokinase or recombinant plasminogen activator (rt-PA) is improved by SSR182289A, a direct orally active thrombin inhibitor, in rabbit models of thrombosis
Saint-Remy J. M. R.	-	Inhibitory effects of human anti-factor VIII monoclonal antibodies and their neutralization by respective anti-idiotypic antibodies using Thrombin Generation Test
Saint-Remy J. M.	-	Deletion of residue Ala2201 in the factor VIII C2 domain impairs FVIII interactions with phospholipids and vWF and results in mild hemophilia A
Saint-Remy J. M.	-	Coagulation factor immunogenicity: where are we going?
Saint-Remy J. M.	-	Response to DDAVP in mild/moderate hemophilia A patients according to the underlying factor VIII genotype
	-	Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor
Saint-Remy J.M.R.	-	Studies of anti-idiotypic polyclonal antibodies developed against antihuman Factor VIII monoclonal antibodies
Saint-Remy J. M.	-	Inhibition of FVIII coagulation activity by FVIII-light-chain-specific antibodies of haemophilia A patient
	-	SPR evaluation of antibody-mediated inhibition of recombinant FVIII (full length and B-domain deleted) binding to von Willebrand factor
Saint-Remy J.-M.	-	An anti-idiotypic mouse monoclonal antibody towards idiotopes of human anti-C2 inhibitors mimics C2 the 3D conformation of C2 and restores Factor VIII activity in vivo
Saito H.	-	Aging and obesity augment the stress-induced expression of tissue factor gene in the mouse
Saito J.	-	Natto Bacillus (Bacillus subtilis natto) as an oral fibrinolytic agent
Saito H.	-	Abnormal subcellular localization of neutrophil nonmuscle myosin heavy chain-A (NMMHCA) is associated with MYH9 mutations in patients with autosomal dominant macrothrombocytopenia with leukocyte inclusions
Saito T.	-	Variation of GPVI levels in platelets: relationship to platelet function at high shear
Saito S.	-	Platelet-derived microparticle preparations for enzyme-linked immunoassay, and the high PDMP level detected in unstable angina patients
Saito H.	-	Ryudocan (syndecan-4) deficiency increases susceptibility to LPS-induced shock in mice
Saitoh M.	-	Anti-thrombotic effect of YM337 on carotid artery thrombi induced in squirrel monkeys by electrical stimulation
Saitta M.	-	Prolonged APTT children undergoing elective tonsillectomy
	-	Anti-protein S antibodies in patients with venous and/or arterial thrombosis
Sakakura M.	-	Usefulness of fully automated measurement of reticulated platelet using the whole blood
Sakalová A.	-	Is infection a risk factor of acute ischemic stroke?
Sakata Y.	-	Hemophilia A gene therapy using the third-generation lentiviral vector – Mouse model
Sakata T.	-	Assessment of diagnostic procedures, ratio method and posterior probability method, for protein C deficiency using protein C and antithrombin activities
Sakata Y.	-	Neonatal injection of human factor VIII induces immune tolerance in murine hemophilia A
Sakharov D. V.	-	Clot penetration and fibrin binding of amediplase
Sakon M. S.	-	The possible role of calpain in cancer mediated vascular endothelial cell (vEC) retraction
Sakurai Y.	-	Localization and activity of ecto-ATP diphosphohydrolase/CD39 in human tissues
Sakurai Y.	-	M-thrombin (Tris-coupled thrombin) is a novel potent agonist of platelet activation with minimum effect on clot formation
Sakurai Y.	-	Hemophilia A gene therapy using the third-generation lentiviral vector – Mouse model
	-	Factor V C2 domain contains major binding site for thrombin
	-	The hemostatic effectiveness of regular infusions of factor VIII concentrates in hemophilia A patients with high responder inhibitors
Sala N.	-	PROS1 mutations that introduce a premature termination codon explain protein S deficiency by nonsense-mediated mRNA decay
Sala M. M.	-	Procoagulant effects of raloxifene in postmenopausal women
Sala N.	-	Human vitamin K-dependent Gas6 gene: exon–intron structure and identification of allelic variants
Saladini A.	-	Impact of prenatal/perinatal events and early FVIII replacement on inhibitor risk in children with severe hemophilia
	-	In vivo recovery, efficacy and safety of solvent/detergent treated plasma in patients with rare inherited bleeding disorders
Salaj P.	-	Good efficacy of low dosing regimen of a FVIII/vWF concentrate in patients with von Willebrand disease
Salatino G.	-	Occurrence of myocardial infarction and PAI-1 4G/5G and ACE I/D gene polymorphisms in patients on chronic dialysis
Salcuni N.	-	Hyperhomocysteinemia is associated with the progression of peripheral arterial disease in type 2 diabetic patients
Saleh M.	-	Tyr1956 and Leu1957 in the factor V C1-domain are required for high affinity binding of factor Va to phospholipid membranes
Salem H. H.	-	Role of the Type Ia PI 3-kinase p110beta isoform in integrin alpha(IIb)beta(3) bi-directional signaling
	-	Cytoskeletal regulation of the adhesive interactions between the platelet GPIb/V/IX receptor and von Willebrand factor
Sales M.	-	New automated von Willebrand factor activity assay to distinguish type 1 and type 2 von Willebrand disease (VWD)
Salge U.	-	Coagulation factor V in normal bronchial epithelial and lung cancer cells
Sallah A. S.	-	Plasma hemostatic markers in patients with malignancy: correlation with tumor progression and response to treatment
	-	Plasma markers of hemostatic activation in patients with cancer and deep venous thrombosis
Salmistraro G.	-	Correlation between internal carotid artery stenosis and hematological risk factors for thrombosis (CAST study): final results
	-	Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study
Salmon G.	-	The interaction of von Willebrand factor with GPIba; induces GPIIb-IIIa-dependent secretion
Salobir B.	-	Utility of in vitro closure time (PFA-100TM) for evaluating platelet related primary hemostasis in dialysis patients
Salomon D. R.	-	Platelet integrin a2 SNP 807C is a predictor of bleeding in Von Willebrand Disease (VWD) type 1
Salomon O.	-	The severely impaired thrombin generation in 5 patients with severe factor XI deficiency and inhibitors is corrected in vitro by recombinant factor VIIa
	-	Cys61stop is the first identified nonsense mutation in the factor X gene causing severe factor X deficiency in 3 unrelated homozygotes of Arab origin
Salomon D. R.	-	The laboratory evaluation of aspirin-resistance in normal, healthy subjects
Salonvaara M.	-	Development of hemostasis in the very low birth weight premature infants
Salsmann A.	-	Involvement of the aIIb subunit in postligand binding signaling events
Salvadó J. M.	-	Transmission electron microscopy of granulocyte inclusions in genetically confirmed MYH9-related disorders
Salvadori M.	-	Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal transplant recipients
Salvi R. M.	-	Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
Salviato R.	-	Intron 1 factor VIII gene inversion in patients with severe hemophilia A
Salviato R.	-	Molecular genotyping of the Italian cohort of patients with hemophilia B
Salvioni A.	-	Platelet-associated Tissue Factor expression in patients with unstable coronary artery disease
Salviú M. J.	-	Prevalence of haemostatic and fibrinolytic abnormalities in women with unexplained embryofetal losses and vascular obstetric complications
	-	Cysteine–homocysteine ratio in patients with C677T mutation of the MTHFR gene
Salviú M.	-	Fibrinolytic activity and response to venous occlusion in activated protein C resistance phenotype
Salviu M. J.	-	Effects of factor VIII (fVIII) levels and activated partial thromboplastin time (aPTT) in activated protein C resistance (APC-R) ratio using two different methods
Salviu M. J.	-	Low molecular weight heparin (LMWH) in pregnant women with mechanical prosthetic heart valves (MPHV)
Samama M. M.	-	Effect of rFVIIa (NovSeven®) on thrombin generation in patients with severe thrombocytopenia
Samama M.M.	-	Optimisation of thrombin inhibition: beliefs and facts
Samama M. M.	-	Non-invasive detection of proximal DVT using bilateral compression ultrasound: methodology for the EXCLAIM study
	-	The role of tissue factor on the inhibition of prothrombin activation and thrombin generation by the synthetic pentasaccharide (fondaparinux)
	-	Risk of pregnancy-related venous thromboembolism (VTE) in 60 hereditary AT-deficient women from 45 families: study of 164 pregnancies
Samama M.M.	-	Concluding comments
Samama M.	-	Suitable Measurement of anti-factor Xa activity
Samama M. M.	-	Effect of Fondaparinux on clot formation after tissue factor pathway activation. A thromboelastography study
	-	Measurement of synthetic pentasaccharide fondaparinux (arixtra) anti-Xa activity
	-	Extended thromboprophylaxis with enoxaparin in acutely ill medical patients with prolonged periods of immobilisation: the EXCLAIM study
Samama M. M.	-	Individualizing the risk of venous thromboembolism in medical and surgical patients: development of the decision matrix for VTE prophylaxis
Samama M. M.	-	The role of tissue factor on the inhibition of prothrombin activation and thrombin generation by the synthetic pentasaccharide (fondaparinux)
Samani N. J.	-	Thrombotic potential may be increased in healthy individuals with a two-generation family history of premature myocardial infarction
Samel N.	-	Comparison of platelet aggregation in venous and arterial blood
Samonigg H.	-	Association of a common 936 C/T polymorphism in the gene of vascular endothelial growth factor and VEGF plasma levels
Sampol J.	-	The uremic retention solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair in vitro
	-	Interest of VASP measurement on patients treated by thienopyridines
	-	Activation of p38 MAPK promotes an endothelial adhesive phenotype in response to anti-phospholipid antibodies
	-	Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration
	-	Evaluation of aspirin resistance by platelet function analyzer (PFA-100™) in patients with acute coronary syndrome®
Sampson B. M.	-	Basal Fibrinogen and FVIII:C Concentrations are not Associated with Polymorphisms in the Interleukin-1 Gene Cluster
Samueloff A.	-	Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study
Samuels K. J.	-	Transgenic mice studies demonstrate a role for platelet factor 4 (PF4) in thrombosis: implications for heparin-induced thrombocytopenia (HIT)
San Miguel J. F.	-	Massive life-threatening lung hemorrhage and successful treatment with recombinant human-activated FVIIa concentrates
Sanak M.	-	Prognostic value of selected genetic variants of platelet glycoprotein receptors in prediction of thrombotic events after percutaneous coronary interventions
	-	Novel polymorphic short tandem repeat in the human a2 integrin gene promoter is associated with GPIa/IIa density on the platelet surface
Sánchez T.	-	Evaluation of HaemosIL HS-CRP. A new latex immunoassay to quantitatively determine C-Reactive Protein (CRP) in citrated plasma, totally automated on coagulation analysers
Sanchez J.	-	Surface deposited fibrin activates factor XII and the intrinsic coagulation pathway
Sanchez Luceros A.	-	Low molecular weight heparin (LMWH) in pregnant women with mechanical prosthetic heart valves (MPHV)
Sánchez Luceros A.	-	Von Willebrand factor cleaving protease (VWFCP) activity in patients with pre-eclampsia history: preliminary results
Sanchez Luceros A.	-	Anti-phospholipid antibodies and hyperhomocysteinemia: response to therapy with folic acid
Sánchez-Gómez S.	-	Local blockade of vWF binding epitopes on damaged vessel wall exposed collagen with Saratin inhibits thrombotic risk at different hemodynamic conditions
Sanchez-Guijo F. M.	-	Massive life-threatening lung hemorrhage and successful treatment with recombinant human-activated FVIIa concentrates
Sanchez-Luceros A.	-	Prevalence of haemostatic and fibrinolytic abnormalities in women with unexplained embryofetal losses and vascular obstetric complications
Sandberg E.	-	A multicenter study on the potency estimation of ReFacto
Sandhu A. S.	-	Multimerin supports platelet adhesion by functioning as an RGD ligand for platelet integrin receptors
Sandhu V.	-	Carboxy-terminal mutations render heparin cofactor II more susceptible to secretory impairment than equivalent mutations in antithrombin
Sandkuijl L. A.	-	Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci
Sandmann G.	-	Why did rFVIIa have no effect in post delivery bleeding? – a case-report
Sands D.	-	A multicenter study on the potency estimation of ReFacto
	-	Variability in factor VIII concentrate measurement: results from SSC Field Collaborative Studies
Sane D.	-	Effects of clopidogrel-aspirin combination vs. aspirin alone on platelet aggregation and major receptor expression in patients with heart failure. For the plavix use for treatment of congestive heart failure (PLUTO-CHF) trial
Sane D. C.	-	Platelet inhibition by valsartan and valeryl 4-hydroxy valsartan: a possible missing link to explain benefits of angiotensin II receptor blockers in patients after acute vascular events
Sanguigni V.	-	Increased platelet superoxide anion production in patients with hypertension: role of AT1 receptors
Sanmarco M.	-	Activation of p38 MAPK promotes an endothelial adhesive phenotype in response to anti-phospholipid antibodies
	-	European forum on antiphospholipid antibodies standardization group: results of the 2nd round on antibeta2glycoprotein I home-made assays
Sano T.	-	Various ratio of n-3/n-6 polyunsaturated fatty acid alters the tendency of thrombosis and progress of atherosclerosis in apoE-/- LDLR-/- double knockout mouse
Sansilvestri-Morel P.	-	Role of NADPH oxidase on mechanisms implicated in anoxia/reoxygenation-induced leukocyte adhesion to HUVECs
Santagostino E.	-	The three I hemophilic study: a comparative study of the morbidity pattern between Asian Indian, Iranian and Italian PWH
Santagostino E.	-	Impact of prenatal/perinatal events and early FVIII replacement on inhibitor risk in children with severe hemophilia
Santagostino E.	-	Allelic heterogeneity of severe factor V deficiency: doubling of the mutational spectrum of the factor V gene, and expression of the identified missense mutations
Santagostino E.	-	Arterio-venous fistula as permanent access for home treatment in children with hemophilia: long-term safety and feasibility
	-	In vivo recovery, efficacy and safety of solvent/detergent treated plasma in patients with rare inherited bleeding disorders
Santamaria A.	-	The 46C®T polymorphism in the F12 gene as a risk factor for venous thrombosis: association after linkage analysis
Santamaría A.	-	The 46C®T polymorphism in the F12 gene is a risk factor for ischemic stroke
	-	The 46C®T polymorphism in F12 gene is a risk factor for coronary artery disease
Santamaria A.	-	Risk of ischemic stroke (IS) associated with plasma levels of thrombin-activatable inhibtor fibrinolysis (TAFI)
Santaro R.	-	Clinical data of subjects with Factor V Leiden or G20210A prothrombin mutation: a single institution experience
Santer M.	-	Cytoskeletal regulation of the adhesive interactions between the platelet GPIb/V/IX receptor and von Willebrand factor
Santoro A.	-	A double-blind placebo-controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter
Santoro C.	-	Hemophilia in pediatrics: clinical experience in a single hemophilia center
Santos M. T.	-	Insufficient thromboxane A2 inhibition in patients with vascular disease chronically treated with aspirin: implications for platelet function
Santos A.	-	TNF-alpha promoter polymorphisms (-238 and -308) in patients with cerebrovascular disease
Santos A. V.	-	A systematic analysis of the effects of a thrombin-specific inhibitor, argatroban in HIT
Santos M. A.	-	Psychologic impact of thrombophilia screening in asymptomatic relatives of carriers of prothrombotic mutations
Santos M. T.	-	Platelet–erythrocyte interactions enhance GPIIbIIIa receptor activation and P-selectin expression during platelet recruitment. These effects are amplified in type I diabetic patients
Santoso S.	-	The platelet glycoprotein Ibalpha HPA-2 polymorphism affects VWF binding, but not thrombin interaction
	-	Cell lines expressing recombinant platelet membrane glycoprotein isoforms as tools for the characterization of antibodies against low frequency alloantigens in neonatal alloimmune thrombocytopenia
	-	The impact of GPIIb-IIIa and GPIa-IIa polymorphisms on the adhesion of platelets to collagen and fibrinogen in a microtiter-plate adhesion system under static and dynamic conditions
	-	Human antibody against CD11b inhibits platelet–leukocyte interaction under high shear
Santuz M.	-	Safety and efficacy of nadroparin for the treatment or prophylaxis of venous thromboembolism in pregnancy
Sanz M. A.	-	Treatment with recombinant activated factor VII of intra-abdominal bleeding associated with disseminated intravascular coagulation caused by septic shock
Sapet C.	-	Activation of p38 MAPK promotes an endothelial adhesive phenotype in response to anti-phospholipid antibodies
Saribeyoglu E.	-	A single dose (0.8 g kg) of intravenous immunoglobulin in children with acute immune thrombocytopenic purpura
Sarich T.	-	Dose-dependent inhibition of thrombosis by melagatran in a nonhuman primate model
	-	Experience of using FEIBA™ to attenuate the effects of anticoagulation on inhibition of thrombogenesis in primates
	-	No influence of alcohol intake on the pharmacokinetics or pharmacodynamics of the oral direct thrombin inhibitor, ximelagatran, in healthy volunteers
Sarif J.	-	Discontinuation of long-term oral anticoagulation (OAC): effects of concomitant administration of low-molecular weight heparin (LMWH) during the termination period – a prospective study
Sarig G.	-	Modulation of systemic and placental hemostatic mechanisms by enoxaparin in women with gestational vascular complications
	-	Mechanisms for acquired activated Protein C resistance in cancer patients
Sarigiannis I.	-	Synthetic tripeptides with specific inhibitory action against Gp-Ib glycoprotein
Saringer J.	-	Evaluation of a venous-return assist device (venowave) to treat post-thrombotic syndrome: a phase II study
Sarkar R.	-	Hemophilia A: total correction in mice and partial correction in dogs with canine FVIII using a new AAV serotype
Sarker K. P.	-	The natural anticoagulant Thrombomodulin has radical scavenging activity and acts as an antioxidant C-type lectin
Sarlomo-Rikala M.	-	PECAM-1 expression in adherent platelets differs from that of thrombi during human microvascular anastomosis
Sarode R.	-	Correlation of supra-therapeutic (ST) International Normalized Ratio (INR) with vitamin-K-dependent factors (VKDF)
Sarode R.	-	Evaluation of platelet function analyzer (PFA-100), whole blood (WB), and platelet rich plasma (PRP) aggregation methods in detecting aspirin resistance
Sarto A.	-	Preconceptional and gestational enoxaparin regimes adjusted to fertility program to prevent preclinical, embryonic and fetal loss in women with Recurrent Pregnancy Loss (RPL) and thrombophilia
Sartor R. B.	-	A single point mutation of asparagine 511 to serine is responsible for the increased rate of cleavage of high molecular weight in Lewis rat, which is genetically susceptible to inflammatory stimuli
Sartor D.	-	Below-knee elastic compression stockings for prevention of the post–thrombotic syndrome in patients with proximal-vein thrombosis: a prospective controlled randomized study
Sartorello F.	-	Interaction of factor VIII and von Willebrand factor investigated in a large cohort of von Willebrand disease patients: evaluation of the type 2N variant prevalence
Sartori M. T.	-	Plasma fibrinolytic capacity and 4G/5G polymorphism of PAI-1 gene in heart and kidney transplant recipients with or without steroid immunosuppression
	-	Pseudogene coamplification mimicking a 14-bp deletion mutation in exon 5 of plasminogen gene: a methodological study
Sartori M. T.	-	Factor VII deficiency associated with severe hemophilia A
	-	A frequent, apparently silent, polymorphism in prekallikrein (Fletcher factor) gene
Sartori D.	-	Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
Sasanakul W.	-	Heterogeneous molecular pattern of Factor VII deficiency associated to cerebral hemorrhage
Sasanakul W.	-	Prevalence of Arg 506 and Arg 306 mutations of the factor V gene in Thai blood donors
Sasankul W.	-	Cost-effectiveness in establishing carrier detection and prenatal diagnosis services in a developing country with limited health resources
Sase T. S.	-	Frequency of biphasic transmittance waveform in the APTT coagulation assay in the patients with underlying diseases of DIC
Sase T.	-	Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with DIC
Sase T.	-	Measurement of tissue factor messenger RNA levels in leukocytes from patients with underlying diseases of disseminated intravascular coagulation
Sass C.	-	Phenotypic sensitivity to activated protein C in healthy families: importance of genetic components and environmental factors in the Stanislas Cohort
Sata M.	-	Phase I study of a novel recombinant human soluble thrombomodulin, ART-123
Sathar J.	-	Critical lower limb ischemia caused by essential thrombocytosis and successful limb salvage using angiographic-guided intra-arterial thrombolysis with rTPA
Sato Y.	-	Coagulation system and inflammation significantly contribute to thrombus formation in ruptured plaques than erosive plaques of acute myocardial infarction
Sato E.	-	EF6265: a new synthetic, potent and selective plasma CPB/TAFIa inhibitor
Sato K.	-	Increased expression of endogenous tissue-type plasminogen activator and matrix metalloproteinase 9 contribute to heparin-produced cerebral hemorrhage after focal cerebral ischemia in mice
Satoh K.	-	Mechanisms of platelet retention in the collagen-coated bead columns
	-	Interaction of the glycoprotein (GP) Ib-IX/V complex with the platelet collagen receptor GPVI
Satoh K.	-	Remnant-like lipoprotein particles potentiate platelet activation under high shear stress assessed by the ‘collagen column’, filled with collagen-coated small beads
Satoh K.	-	Differential role of phosphatidylinositol 3-kinase in glycoprotein Ib-mediated platelet activation
	-	Platelet endothelial cell adhesion molecule-1 (PECAM-1) of platelets is cleaved under high shear stress
Sattar N.	-	The G>T point mutation in codon 34 of the factor XIII gene and the risk of pre-eclampsia
Sauls D. L.	-	Diet-induced hyperhomocysteinemia leads to a dysfibrinogenemia, elevated levels of plasminogen activator inhibitor-1 (PAI-1) and delayed clot lysis
Saulters J.	-	Platelet and inflammatory changes induced by angioplasty and brachytherapy
Saut N.	-	Polymorphisms in the thrombomodulin gene as risk factors for myocardial infarction (HIFMECH study)
Sautiere K.	-	Tissue factor predicts long-term outcome after percutaneous coronary revascularization
Savage B.	-	Platelet septins and enhanced platelet function in SEPT5-deficient platelets
Savchenko S.	-	Nitric oxide, endothelin-1 production and antithrombogenicity of endothelium in essential hypertension
Savchuk A.	-	Influence of fibrin clot surface structures on processes interaction with fibrinolytical systems components
Savi P.	-	Deficiency in one Gas6 receptor (Axl, Sky or Mer) protects mice against thrombosis because of a platelet dysfunction
Savic A.	-	The FV Leiden, FII G20210A and MTHFR C677T mutations in healthy and thrombophilic Yugoslav population
Savidge G. F.	-	Different risk of pulmonary embolism development in patients with deep-vein thrombosis from North-Western Russia having either factor V Leiden or prothrombin G20210A mutation
	-	Use of specific reference ranges for equal volume mixing studies in lupus anticoagulant assays
	-	Increased platelet activation in hyperhomocysteinemic patients
	-	A retrospective evaluation of the use of B-domain deleted recombinant Factor VIII (ReFacto®) administered by continuous infusion during surgical procedures
Savidge G.	-	SPR evaluation of antibody-mediated inhibition of recombinant FVIII (full length and B-domain deleted) binding to von Willebrand factor
	-	Characterization of anti-factor VIII antibodies using Time-Resolved Fluoroimmunoassay
Savino J.	-	Characterization of the von Willebrand factor present in circulating PMN
Savion N.	-	Cone and plate(let) analyzer as a diagnostic tool in various types of thrombotic thrombocytopenic purpura and haemolytic uremic syndrome
	-	Monitoring the combined effect of integrilin, clopidogrel and aspirin in patients with myocardial infarction by Cone and Plate(let) Analyzer
	-	Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins
Savoia H. F.	-	Thrombolytic therapy with tissue plasminogen activator (tPA), analysis of safety and outcome in children
Savoia H.	-	Reference ranges for hemostatic parameters in children
Savoia H. F.	-	Arterial thromboembolic disease in infants and children
	-	Anti-coagulation clinics for children achieve improved warfarin management
	-	Prospective cohort study of paediatric venous thrombosis
Savopoulos CH.	-	Acute ischemic strokes: LMWHs or aspirin administration and laboratory monitoring
Savopoulos C.	-	Acute ischemic strokes: LMWHs or aspirin administration and laboratory follow-up
Savushkin A. V.	-	Thrombocyte retraction does not strength blood clot
Sawai T.	-	Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with DIC
Sayed A. A. R.	-	Long-term RAGE-mediated NF-kB activation in diabetic neuropathy and its role in loss of pain perception
Sayeed M. M.	-	Alterations in intraplatelet Ca2+ mobilization by functional antiheparin-PF4 antibodies: Implications in the signaling mechanisms during HIT pathogenesis
Sayer M. S.	-	Prediction and prevention of thrombosis during pregnancy and oestrogen use
Scaff M.	-	Inherited prothrombotic risk factors in a Brazilian cohort with CVT
	-	Acquired prothrombotic-associated factors in cerebral venous thrombosis (CVT)
Scalet P.	-	Oral anti-coagulation and dental extraction
Scalone L.	-	Conjoint analysis: a new technique to quantify individual's preferences, to develop outcome measures and to determine optimal treatment patterns in hemophilia
Scanavini D.	-	Modulation of factor V levels in plasma by intragenic polymorphisms
Scannapieco G.	-	Risk factors for venous thromboembolism in chronically bedridden patients admitted to the Hospice Unit
Scannapieco G.	-	Visceral vein thrombosis: retrospective analysis of 53 cases in five Italian thrombosis
Scannapieco G. L.	-	Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
Scannapieco G.	-	Management of oral anticoagulant therapy in the perioperative period: preliminary results of the application of an operative protocol
Scapoli G. L.	-	The G>T point mutation (Val34Leu) in the Factor XIII-A subunit gene in venous leg ulcers
Scarabin P.	-	Oral not transdermal estrogen replacement therapy is associated with venous thromboembolism risk
Scaraggi F. A.	-	Short-term effects of raloxifene on the main anti-coagulant systems in postmenopausal women
Scaringell W. A.	-	Hemophilia as a model for analysis of human germ-line mutagenesis: frequent mosacism and low male to female sex ratio for G:C®A:T nonCpG transitions and the first observation of a nucleotide bi-mutation are consistent with effects in early embryogenesis
Scarpa R. M.	-	A clinical outcome-based prospective study on venous thromboembolism in cancer surgery: the @RISTOS project
Scarselli G.	-	Effects of HRT with estradiolvalerate 2-mg + levonorgestrel 75 µg (NUVELLE®) on clotting and lipid profile
Scenna G.	-	Thrombosis do not recur at conventional dose oral anticoagulation (INR 2–3) in primary anti-phospholipid syndrome: comparison with inherited thrombophilia at similar INR
Schaefer H. G.	-	The effect of BIBR 953 ZW, the active form of the oral direct thrombin inhibitor BIBR 1048, on the prolongation of aPTT and ECT in orthopedic patients: a population pharmacodynamic study
Schaeffer P.	-	Thrombolysis induced by streptokinase or recombinant plasminogen activator (rt-PA) is improved by SSR182289A, a direct orally active thrombin inhibitor, in rabbit models of thrombosis
	-	Deficiency in one Gas6 receptor (Axl, Sky or Mer) protects mice against thrombosis because of a platelet dysfunction
Schäfer W.	-	Virus validation studies utilizing model viruses are relevant for west Nile virus
Schäfer A.	-	Inhibition of platelet activation in congestive heart failure by selective aldosterone receptor antagonism and angiotensin-converting enzyme inhibition – role of platelet VASP phosphorylation
	-	Platelet activation and platelet VASP phosphorylation in mice with streptozotocin-induced diabetes mellitus – association with endothelial dysfunction and reduced nitric oxide bioactivity
	-	Novel role for the membrane-bound chemokine fractalkine as a pathophysiologically relevant mechanism in platelet activation and adhesion
Schaffner-Reckinger E.	-	Involvement of the aIIb subunit in postligand binding signaling events
Schaffner-Reckinger E.	-	Interacting sites within Talin and the integrin b3 cytoplasmic tail
Schalkwijk C. G.	-	Atorvastatin strongly reduces C-reactive protein, but shows less marked effect on other prognostic inflammatory markers
Schalkwijk A.	-	Symptomatic plaques of type 2 diabetic patients show more plaque complications but similar expression patterns of markers for coagulation and inflammation compared to nondiabetic controls
Schambeck C.	-	Factor XI: its role in thrombotic disease of patients with factor V Leiden
Schandene L.	-	Phenotype of T cells in human abdominal aortic aneurysm
Scharf J.	-	Application of human factor XIII in children with massive pleural effusions after open heart surgery
Scharf R. E.	-	Influence of anti-thrombin on platelet adhesion onto immobilized fibrinogen in simulated low flow in vitro system
	-	Platelet receptor polymorphism HPA-1b and the G20210A mutation of the prothrombin-gene are risk determinants of vascular access thrombosis in hemodialysis patients
	-	Lipid levels and homocysteine are determinants which influence the epinephrine–collagen- and ADP–collagen-closure time
	-	High levels of plasma markers of coagulation factor VIII:C and von Willebrand factor are independent risk determinants of pregnancy-associated venous thromboembolism
	-	Rapid induction of immune tolerance with von Willebrand factor containing factor VIII concentrate in acquired hemophilia A
	-	High levels of plasma markers of coagulation factors (I, VIII:C, XI, XII), inflammation, and hyperhomocysteinemia are risk determinants of pre-eclampsia and HELLP syndrome
Scharrer I.	-	Clinical manifestations of the antiphospholipid syndrome in patients with highly elevated anticardiolipin antibodies
	-	ADAMTS-13 activity and corresponding inhibitor titers during plasma exchange therapy in 13 pts with Thrombotic Thromobcytopenic Purpura (TTP)
	-	Mild ADAMTS-13 deficiency in patients with ischemic stroke
	-	The antiphospholipid syndrome and cerebral manifestations
	-	Important Role of FV G1691A and FII G20210A in women with pregnancy loss without apparent causes
	-	Rituximab – a challenge for the therapy of inhibitors to factor VIII
	-	The administration of recombinant coagulation factor VIIa (rFVIIa) during neurosurgical procedures
Scharrer TH.	-	Association between factor XIII Val34Leu polymorphism and risk of ischemic stroke in young patients
Scharrer I.	-	Increased thrombophilic abnormalities in patients with cranial dural arteriovenous fistulae
	-	Incidence of venous thrombosis in carriers of familial thrombophilia with a personal history of venous thrombosis
	-	The development of inhibitors directed against factor VIII after continuous infusion of factor VIII concentrates in patients with hemophilia A
	-	IgM-anticardiolipin – marker of a previous thrombosis?
	-	The risk of postoperative hemorrhage after intracranial surgery following early Nadroparin administration – results of a prospective study
	-	Malignancy and metastasis is not associated with decreased ADAMTS-13 activity in patients with brain tumors and prostate tumors
Schattner M.	-	Recombinant Lopap (a prothrombin activator from Lonomia obliqua) has a very conservative structure of lipocalins
	-	Platelet responses mediated by venom snake metalloproteases (MP1 and MP3)
	-	Characterization of the von Willebrand factor present in circulating PMN
	-	Prostacyclin protects basal and nitric oxide-induced megakaryocytes apoptosis
Schatz S.	-	Surface exposed mutation W2313A in the C2-domain of FVIII results in defective secretion of otherwise functional protein
Schaub R. G.	-	Comparative response of plasma VWF in normal and von Willebrand disease dogs to up-regulation of VWF mRNA by Interleukin-11 vs. Weibel–Palade body release by Desmopressin (DDAVP)
	-	Role of platelet-leukocyte–endothelium interactions in neointimal hyperplasia
Scheibel E.	-	Hand computer and Internet for collection and presentation of patient diary data in a Nordic clinical multicenter safety surveillance study of ReFacto®
Scheiflinger F.	-	Surface exposed mutation W2313A in the C2-domain of FVIII results in defective secretion of otherwise functional protein
	-	Towards the development of a recombinant von Willebrand factor-cleaving protease (ADAMTS-13)
	-	ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS-13
Scheiner T.	-	Resveratrol and trolox scavenge hydroxyl radicals produced in platelets activated by collagen
	-	Resveratrol and trolox scavenge hydroxyl radicals produced in platelets activated by collagen
	-	A monoclonal antibody to the fibrinogen g chain alters clot structure and properties by producing thinner fibrin fibers arranged in bundles
Schellinger S.	-	The impact of factor V Leiden on the endothelial cytokine response to coagulation activation modulated by drotrecogin alfa (activated)
Schellong S.	-	Non-invasive detection of proximal DVT using bilateral compression ultrasound: methodology for the EXCLAIM study
Schellong S.	-	Extended thromboprophylaxis with enoxaparin in acutely ill medical patients with prolonged periods of immobilisation: the EXCLAIM study
Schellongowski P.	-	Treatment of adults with sepsis-induced coagulopathy and purpura fulminans with a plasma-derived protein C concentrate (Ceprotin®)
Schenk J. F.	-	On the role of platelets, and homocysteine in thrombotic patients, healthy controls and mutant carriers of methylentetrahydrofolate reductase (‘MTHFR’) (C677T)
Schenk J. F.	-	Evidence of C677T methylentetrahydrofolate reductase (‘MTHFR’) and hyperhomocysteinemia (HH) – causal or casual coexisting risk factors?
Schenk J. F.	-	Thrombophilia – from the roots to the base of evidence. Preliminary results on platelet function and rheologic parameters and the necessity of prospective multicentre cohort trials
Schenone M.	-	FIX Gla Domain: Identification and characterization of residues involved in the phosphatidylethanolamine/phosphatidylserine phospholipid membrane interaction
Scheuer T.	-	Malignancy and metastasis is not associated with decreased ADAMTS-13 activity in patients with brain tumors and prostate tumors
	-	The risk of postoperative hemorrhage after intracranial surgery following early Nadroparin administration – results of a prospective study
Schiavone A.	-	Determination of the interassay variability of d-Dimer measurements near the critical cut-off point used for the exclusion of venous thromboembolism, on the MDA-180 coagulation analyzer
	-	Precision of the PFA-100 platelet function analyzer: A practical and cost effective method of quality control (QC) for the clinical coagulation laboratory
Schiavoni M.	-	In vivo recovery, efficacy and safety of solvent/detergent treated plasma in patients with rare inherited bleeding disorders
	-	Recombinant activated Factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor
Schiedner G.	-	Gene therapy for hemophilia A with high-capacity adenoviral vectors: preclinical evaluation in hemophilic mice and dogs
Schillinger M.	-	A microsatellite polymorphism in the Heme Oxygenase – 1 gene promoter is associated with increased serum bilirubin and HDl levels but not with a decreased risk for coronary artery disease
Schinco P. C.	-	Recombinant activated Factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor
Schindewolf M.	-	Safe anti-coagulation with danaparoid in pregnancy and lactation
Schindewolf M.	-	The German thrombophilia-registry – first results: Women specific risk factors and venous thrombosis
Schini-Kerth V. B.	-	Thrombin induces the expression of pro-MMP-2 and its conversion to MMP-2 in vascular smooth muscle cells: both responses are inhibited by red wine polyphenols
Schinke B.	-	Activated platelets induce migration, proliferation and gene expression in human vascular endothelial cells
Schiphorst M.	-	An in vivo model to study von Willebrand factor (VWF) clearance: fundamental aspects and application to the Arg1205His Vicenza mutation
Schiralli F.	-	Coagulation and complement inhibitors levels predict outcome in patients with severe sepsis
	-	Chemotherapy-induced activation of hemostasis: the role of d-dimer
Schirm J.	-	High-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in congenital coagulation disorders. A randomized, double-blind, placebo-controlled clinical trial
Schlammadinger A.	-	Anti-phospholipid syndrome during pregnancy: only the high-dose of LMWH thromboprophylaxis is successful
Schlammadinger Á.	-	The role of platelet concentrate in the treatment of von Willebrand's disease
Schlegel N.	-	Platelet function peculiarities throughout childhood: a flow cytometric study from healthy premature new-borns up to 15-year-old-children
Schleicher E.	-	Long-term RAGE-mediated NF-kB activation in diabetic neuropathy and its role in loss of pain perception
	-	Commercially available protein infusion solutions can be modified by nonenzymatic glycation which causes NFkappaB-dependent expression of procoagulant and inflammatory gene products
Schlelgel N.	-	The study on phenotype and genotype of Protein C in a Chinese family with hereditary Protein C deficiency
Schliamser L.	-	Warfarin and overanticoagulation
Schlichter A. J.	-	Anticoagulation therapy outcome in children after extracardiac conduit Fontan operation
Schmaier A. H.	-	Recombinant prolylcarboxypeptidase activates plasma prekallikrein
Schmaier A.	-	The bradykinin B2 Receptor knockout mouse is protected from thrombosis
Schmaier A. H.	-	Mapping the interaction between uPAR and high molecular weight kininogen
Schmidt A. M.	-	At least two distinct pathways generating reactive oxygen species mediate endothelial VCAM-1 induction by advanced glycation endproducts
Schmidt S.	-	Prognostic value of activated protein C levels in patients with severe sepsis
Schmidt A. M.	-	Long-term RAGE-mediated NF-kB activation in diabetic neuropathy and its role in loss of pain perception
Schmidt M.	-	Influence of platelet glycoprotein IIIa PlA polymorphism on mean platelet volume and vWF after coronary stent implantation
Schmidt A. E.	-	The structural role of glycine-193 in serine proteases: active site investigations of Gly193Val mutant of factor IXa and crystal structure of factor VIIa/soluble tissue factor with a reversible inhibitor
Schmits S.	-	CYP2C9 polymorphisms have differential effects on acenocoumarol metabolism, but do not increase bleeding risk
	-	CYP2C9 polymorphisms have differential effects on the quality of acenocoumarol treatment
Schmitt J.	-	Detection of lupus anticoagulant: development of a new precise, sensitive and specific aPTT-based assay
Schmitt L.	-	Quality assessment of anti-coagulation dose management: comparative evaluation of measures of time-in therapeutic range
Schmugge M.	-	Underlying platelet function disorders and von Willebrand disease in children with epistaxis or menorrhagia
	-	Stability of dilutions of the recombinant factor VIII Kogenate FS stored in syringes
	-	Triple heterozygosity in the alphaIIb gene of a patient with Glanzmann thrombasthenia and platelets with a low alphaIIbbeta3 content
Schmutzler-Baas A.	-	Duplex screening for quality assurance of postoperative thromboembolism prophylaxis in neurosurgery – Krefeld Study ‘Thrombo 2000’
Schneider M.	-	Postpartum levels of activated TAFI (TAFIa) in patient plasmas
Schneider E.	-	Treatment of recurrent arterial thrombosis with hirudin in congenital afibrinogenaemia
Schneider M.	-	A study of the protection of plasmin from antiplasmin within an intact fibrin clot during the course of clot lysis
Schneider B.	-	Assessing the risk of recurrence in patients with a first spontaneous venous thromboembolism by use of D-dimer
Schneppenheim R.	-	Molecular and clinical markers for the diagnosis and management of type 1 von Willebrand's disease (VWD): The progress of a European collaboration
	-	Sensitivity and specificity of PFA-100® vs. bleeding time in the diagnosis of type 1 von Willebrand disease (VWD)
Schneppenheim R.	-	Splice site mutations of the von Willebrand factor gene in patients previously diagnosed with von Willebrand disease type 1
Schneppenheim R.	-	Use of recombinant factor VIIa in severe acquired coagulopathies in childhood
	-	An improved multimeric analysis identifies a subgroup of patients with Type 1 von Willebrand disease characterized by reduced VWF:RCo/Ag ratio
	-	In vitro expression of 4 novel mutations identified in type 1 von Willebrand disease patients
	-	Classification of VWD on the move
	-	Co-segregation of Von Willebrands disease type 1 phenotype and Von Willebrand factor gene haplotypes: first results from the multicenter study molecular and clinical markers for the diagnosis and management of type 1 Von Willebrands disease
Schneppenheim R.	-	Comparative expression of recombinant wildtype and mutant von Willebrand factor cleaving protease ADAMTS13
Schneppenheim R.	-	Evaluation of a new quantitative, rapid test (VWF-LIA) for the diagnosis of type 1 VWD
Schnider T.	-	Nonmechanical intraoperative bleeding diathesis shows properties of a consumptive disorder allowing preoperative risk stratification
Schnog J.	-	Elevated steady state serum sVCAM-1 levels occur from an early age in sickle cell patients, but are not related to vasoocclusive crises and acute chest syndrome frequency
	-	Reduced protein C and S activity and sickle cell disease severity
	-	Levels of endothelial activation markers, D-dimer fragments and pro-inflammatory cytokines and sickle cell disease severity
Schnurr T.	-	Patients receiving long-term warfarin therapy prefer INR testing with capillary fingerstick over venous blood testing
Schobeß R.	-	Factor XII-deficiency is a risk factor for ischaemic stroke but not for venous thrombosis in children
Schober J. M.	-	Effect of cellular and receptor activation on the extent of integrin alphaIIb beta3 internalization
Schobess R.	-	Elevated factor VIIIC and further prothrombotic risk factors in paediatric venous thrombosis and stroke: a multivariate analysis
	-	Sinus venous thrombosis in children – a multifactorial etiology
Schoenauer V.	-	The effect of pretreatment with clopidogrel on platelet and coagulation activation in patients with stable angina undergoing elective coronary stenting
Schoenfeld H. J.	-	The active conformations of Factor VIIa and Factor IXa: biochemical, biophysical, chemical and crystallographic studies
Schoenmakers S. H. H. F.	-	Coagulant phenotype determines the outcome of septic peritonitis
	-	Blood-borne tissue factor aggravates the outcome of endotoxemia
	-	Differential effects of tissue factor haploinsufficiency during LPS stimulation
Schoenwaelder S. M.	-	Phosphoinositide 3-kinase beta (PI3Kb): a novel target for antithrombotic therapy
Schoenwaelder S. M.	-	Role of the Type Ia PI 3-kinase p110beta isoform in integrin alpha(IIb)beta(3) bi-directional signaling
Schoenwaelder S. M.	-	Integrin aIIbb3 outside-in calcium signals sustain platelet–fibrinogen interactions under flow
Schoevaert D.	-	Platelet translocation on von Willebrand factor is inhibited by RGDS peptide at high shear rate
Scholtz S. C.	-	The effect of refined and red palm olein compared to sunflower oil on lipids and homeostatic factors in hyperfibrinogenemic patients
Scholz T.	-	Using a modified thrombin generation assay for potency assessment of B-domain deleted recombinant factor VIII (ReFacto®)
Scholz U.	-	The influence of the prothrombin mutation 20210 GA and the level of prothrombin on the thrombin generation
	-	Platelet mediated thrombin generation depends on F VIII and Factor IX in a complex way: evidences for the Cell-based model of hemostasis
Scholz T.	-	Activated platelets and platelet-derived microvesicles (PMV) transfer tissue factor (TF) to monocytes but not to neutrophils
Scholz U.	-	GP IIb-IIIa antagonists and thrombin generation
Schömig A.	-	Tissue factor stimulates migration by activation of the mitogen-activated proteinkinase p38 and the GTPase Rac1
	-	Proteolysis of tissue factor pathway inhibitor-1 on circulating microparticles after thrombolysis in acute myocardial infarction contributes to thrombin formation
Schönauer V.	-	The effect of b-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolism
Schonenberg D.	-	Thromboprophylaxis in orthopedic surgery: Clinical practice in the Netherlands
Schoolmeester A.	-	Identification of a novel inhibitory monoclonal antibody against the integrin a2b1
Schoolmeester A.	-	Integrin activation upon human platelet adhesion to collagen under flow
Schoolmeester A.	-	A new platelet activation marker specific for activated integrin alpha2beta1: monoclonal antibody IAC-1
Schorer A. E.	-	Venous thromboembolism is common but does not alter survival in glioblastoma multiforme
Schramm W.	-	Epitopes of factor VIII inhibitors analyzed by peptide-arrays
	-	Rapid and automated quantification of the kinetics of thrombin formation using the Thrombin Dynamics Test (TDT)
	-	Health-related quality of life in adults with hemophilia: the patient perspective
	-	Hemophilia care in the new millenium: a global perspective
	-	Analysis of mRNA in a panel of hemophilia A patients with no detectable mutation in the coding regions of the factor VIII gene
Schreuder H.	-	Crystal structure of benzamidine-Factor VIIa/soluble tissue factor at 1.87 Å resolution: mapping of calcium, magnesium, sodium, and zinc sites in the Factor VIIa structure
	-	The structural role of glycine-193 in serine proteases: active site investigations of Gly193Val mutant of factor IXa and crystal structure of factor VIIa/soluble tissue factor with a reversible inhibitor
Schrijver I.	-	Intrauterine growth retardation and recurrent pregnancy loss associated with prothrombin gene variants 20221C > T and 20209C > T
Schrijver I.	-	Novel factor V mutations in three separate families resulting in factor V deficiency and bleeding
Schröder J.	-	Analysis of mRNA in a panel of hemophilia A patients with no detectable mutation in the coding regions of the factor VIII gene
Schröder C.	-	A novel recombinant factor VIII produced by a human cell line functionally restores coagulation deficits in a mouse model of hemophilia A
Schroeder W.	-	Molecular genetic analysis of gene variants in the 5' flanking region of the FVII gene: Identification of a novel mutation in a German family
Schroeder A.	-	Expression of Plasminogen activator inhibitor-1 (PAI-1) mRNA in human ciliary processes and determination of PAI-1 in human aqueous humor
Schroeder V.	-	Seven novel mutations leading to congenital coagulation factor XIII deficiency
Schroeder J.	-	Genetic mechanisms underlying the clinical manifestation of hemophilia A in females
Schroer K.	-	Evidence for a functionally active protease-activated receptor-3 in human vascular smooth muscle cells
Schroth M.	-	Application of human factor XIII in children with massive pleural effusions after open heart surgery
Schroth P.	-	Clinical evaluation of an advanced category recombinant FVIII, anti-hemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM) in surgical settings
Schubert K.	-	Oral infection as a risk factor of atherosclerosis: first results of an intervention study
Schubert U.	-	Regulation of neovascularization by a-defensins: a link between inflammation and angiogenesis
Schuepbach R.	-	Treatment of recurrent arterial thrombosis with hirudin in congenital afibrinogenaemia
Schuettrumpf J.	-	Improving efficacy of gene therapy of hemophilia B by the use of mutant FIX variants
Schuh A.	-	The epitope of the CD109 monoclonal antibody 8A3 overlaps with the epitope of Gov antibodies: implications for Gov antibody detection
Schulman S.	-	Prophylaxis against bleeding with a factor VIII-von Willebrand factor concentrate in hemophilia A with high titer inhibitor
Schulman S.	-	Overall hemostasis and thrombin activatable fibrinolysis inhibitor (TAFI) – dependent fibrinolysis in patients treated with the novel oral thrombin inhibitor – ximelagatran
Schulman S.	-	Unresolved issues in anticoagulant therapy
	-	A retrospective evaluation of the use of B-domain deleted recombinant Factor VIII (ReFacto®) administered by continuous infusion during surgical procedures
Schulman S.	-	Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins
	-	Determination of the different forms of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with hemophilia A, hemophilia B and von Willebrand disease
	-	Hand computer and Internet for collection and presentation of patient diary data in a Nordic clinical multicenter safety surveillance study of ReFacto®
	-	Extended secondary prevention with the oral direct thrombin inhibitor ximelagatran for 18 months after 6 months of anticoagulation in patients with venous thromboembolism: a randomized, placebo-controlled trial
	-	Treatment of patients with VWD requiring elective surgery with a pasteurized von Willebrand Factor/FVIII concentrate (Haemate®P) – the use of a PK-guided approach
Schulte V.	-	Normal arterial thrombus formation in integrin a2-deficient mice
Schulte V.	-	Targeting of the collagen binding site on glycoprotein VI is not essential for in vivo depletion of the receptor
Schulte T.	-	Factor XII-deficiency is a risk factor for ischaemic stroke but not for venous thrombosis in children
Schulte V.	-	Glycoprotein Ib and integrin a IIbb 3 contribute to GPVI-dependent vWF-collagen induced thrombus formation under flow
Schulte S.	-	Identification of a Factor IX cleaving protease and efficient reduction in a high purity Factor IX manufacturing process
Schulte T.	-	Elevated factor VIIIC and further prothrombotic risk factors in paediatric venous thrombosis and stroke: a multivariate analysis
Schultz J. E.	-	P-selectin-dependent lung colonization of melanoma cells is targeted by heparin treatment
Schultz C.	-	Heparinase I digestion of tinzaparin: a novel approach to neutralize the anti-coagulant and potential hemorrhagic effects of low molecular weight heparin
Schultz C.	-	Fibrinopeptide-A generation inhibition by anti-Xa drugs and its correlation with activated clotting time
	-	Pharmacodynamic profile of Intimatan as an antithrombotic agent for venous thrombosis
	-	Pharmacodynamics and pharmacokinetics of anti-Xa potency adjusted heparin derived oligosaccharides in nonhuman primates: implications in dosage optimization
	-	Inhibition of procarboxypeptidase U by tinzaparin. A potential mechanism of its profibrinolytic actions
Schultz M.	-	Alterations in lipoprotein homeostasis during experimental and clinical sepsis in primates
Schulz C.	-	Novel role for the membrane-bound chemokine fractalkine as a pathophysiologically relevant mechanism in platelet activation and adhesion
Schulz J. B.	-	Long-term RAGE-mediated NF-kB activation in diabetic neuropathy and its role in loss of pain perception
Schulz A.	-	Genetic profiling of 20 patients with FVII deficiency by dHPLC and sequence analysis: detection of 7 novel mutations
Schumann B.	-	The coordinated transcription of genes encoding regulators of cell cycle progression revealed by expression profiling upon calcium ionophore A23187 treatment of B lymphoblasts from a patient with Scott syndrome
Schumann A.	-	PADA-HIT: A new POCT method for ultra-fast detection of HIT II antibodies
Schumann S. A.	-	Shiga toxin with antecedent TNF-a induces enhanced tissue factor activity on human glomerular, but not on umbilical vein, endothelial cells
Schumann A.	-	PADA – fast and quantitative monitoring of blood platelet adhesiveness
Schumann S. A.	-	Globotriasylceramide (Gb3) and blood-borne tissue factor (TF) colocalize with platelets during platelet adhesion/aggregation onto a collagen-coated surface exposed to flowing blood
Schumock G. T.	-	Factors that influence the prescribing of low-molecular-weight heparins (LMWHs) in community hospitals: opinions of physicians, clinical pharmacists, and formulary committee members
Schurgers L. J.	-	Mutations in genes of the gamma-glutamyl carboxylase and the vitamin K epoxidase reductase complex are responsible for the phenotype of hereditary combined deficiency of vitamin K-dependent clotting factors
Schussler O.	-	Intravenous immunoglobulins G modulate calcium signals, von Willebrand factor secretion and nitric oxide metabolism in human endothelial cells
Schützer K.	-	No influence of alcohol intake on the pharmacokinetics or pharmacodynamics of the oral direct thrombin inhibitor, ximelagatran, in healthy volunteers
Schved J. F.	-	Development of inhibitors against factor VII in patient with severe factor VII deficiency
Schwaab R.	-	Response to DDAVP in mild/moderate hemophilia A patients according to the underlying factor VIII genotype
	-	Analysis of mRNA in a panel of hemophilia A patients with no detectable mutation in the coding regions of the factor VIII gene
Schwabb R.	-	Epitopes of factor VIII inhibitors analyzed by peptide-arrays
Schwaninger M.	-	Long-term RAGE-mediated NF-kB activation in diabetic neuropathy and its role in loss of pain perception
Schwarts E. I.	-	Molecular risk factors are important causes for the thrombosis in childhood
Schwarz H. P.	-	Proteases derived from Ficus carica activate human factor X
Schwarz M.	-	Human, conformation-specific, anti-GPIIb/IIIa (aIIbb3) single-chain antibodies generated by differential phage-display: a new generation of platelet inhibitors specific for the activated GPIIb/IIIa receptor?
Schwarz H. P.	-	Differentiation of factor VIII-specific memory B cells into anti-factor VIII antibody-secreting cells requires direct interaction between memory B cells and activated T cells but is not dependent on factor VIII-specific T cells
Schwarz M.	-	The Jarvik 2000 artificial heart does not affect the activation status of platelets
Schwarz H. P.	-	Analytical comparison of recombinant and plasma-derived activated protein C (APC)
	-	Changes in ADAMTS13 (vWF cleaving protease) activity after induced acute release of von Willebrand factor
	-	Towards the development of a recombinant von Willebrand factor-cleaving protease (ADAMTS-13)
Schwarz U. R.	-	Activated platelets induce migration, proliferation and gene expression in human vascular endothelial cells
Schwarz H. P.	-	Monitoring the pharmacokinetic of inhibitor-bypassing agents with a new thrombin generation assay
Sciacca R.	-	Thrombin generation after ischemic stroke: the hemostatic system activation study (HAS)
Sciuccati G.	-	Cerebral sinovenous thrombosis (SVT) in children: a prospective 10-year registry in Argentina
	-	Biological and clinical DDAVP response in children with von Willebrand disease (VWD)
	-	Venous thromboembolism (VTE) in children: A prospective 10-year registry in Argentina
	-	Arterial ischemic stroke (AIS) in children: a prospective 10-year registry in Argentina
Sclar D.	-	Economic modeling of full-length anti-hemophilic factor (recombinant), plasma/albumin-free method (rAHF-PFM), vs. B-domain deleted rFVIII (BDDrFVIII) in previously treated patients (PTPs) with hemophilia A
	-	Economic evaluation of anti-D immunoglobulin in the treatment of immune thrombocytopenic purpura in adults in the United Kingdom
Scorpiglione N.	-	Are daily doses of 80 and 160 mg of aspirin bioequivalent? A pharmacokinetic and pharmacodynamic approach
Scott J. P.	-	Assay of the von Willebrand factor propeptide in patients with type 1 von Willebrand disease (VWD) and the identification of patients with a S2179F mutation in the D4 region of von Willebrand factor
Scott B. T.	-	Heritability of clotting factors and the prothrombotic state: results from a large thrombophilic pedigree of French Canadian descent with Type I protein C deficiency
Scott R. S.	-	Plasma adiponectin and the metabolic syndrome
Scott B.	-	Asymptomatic venous thrombosis is a frequent event in protein C deficiency: a systematic ultrasound assessment of 208 family members with the 3363-C insertion mutation (IPCI: International Protein C Investigation)
Scourgie F.	-	Using ETP to predict which factor V Leiden heterozygotes will suffer from venous thrombo-embolism
Scriven N.	-	Baseline characteristics, risk factor profile and outcomes of patients treated for venous thromboembolic disease with low molecular weight heparin (enoxaparin) – the Venous Thromboembolism Registry (VERITY)
Scully M. F.	-	Blood transfusion is associated with an enhanced pro angiogenic state
Scully M.-F.	-	An evaluation of existing measurement methods in assessing menstrual blood loss in women with hereditary bleeding disorders
Scully M. F.	-	Anti-angiogenic activity of heparins and anti-thrombin
Scully M.	-	The influence of the substitution of arginine within the RGD tripeptide motif of dendroaspin on its activity as a potent inhibitor of platelet aggregation and cell adhesion
Scully M.	-	High affinity heparin binding proteins are exposed on the surface and microvesicles of TF bearing cells and diminish heparin-mediated anticoagulation
Scully M. F.	-	Studies to define the clinical impact of ‘mild’ hemophilia A in a large kindred in Newfoundland and Labrador
Scully M. F.	-	Evidence supporting a functional role for the metal binding site observed within the protease domain of Factor IXa
Scully M.	-	Phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis
Scully M. F.	-	Heparin neutralising agents instigate the binding of heparin to live cells
Scully M.	-	Development of bifunctional inhibitors of both platelet aggregation and factor Xa
Seal J.	-	A prospective study examining the effect of a two milligram dose of oral Konakion given to patients with an INR > 8
Seaume H.	-	Safety and efficacy of Fibrogammin P® for the treatment of patients with severe FXIII deficiency
Sebbag L.	-	Identification and characterisation of MIP-1b and VE-Cadherin as important markers of acute rejection after human heart transplantation
Sedano C.	-	Successful use of recombinant FVIIa (Novoseven) for severe bleeding in a patient undergoing bone marrow transplantation refractory to standard hemostatic support
	-	Recombinant Factor VIIa as hemostatic agent in acquired von Willebrand disease
Sedlák P.	-	Is infection a risk factor of acute ischemic stroke?
Sedlis S. P.	-	CD39 ecto-nucleotidase activity (metabolizing ATP to ADP to AMP) constitutes a homeostatic mechanism for control of platelet reactivity, depending on the ratio of ADPase to ATPase activity. Results from patients with coronary artery disease
Segal H.	-	‘Aspirin resistance’ detected by high shear platelet function testing within the pilot phase of the Oxford Vascular Study (OXVASC)
Segal H. C.	-	Increased circulating cardiovascular risk factors in obstructive sleep apnoea and the effect of CPAP therapy
Segal S.	-	Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study
Segal H. C.	-	Markers of hemostatic activation and protein Z in acute stroke and myocardial infarction: a community based pilot study
Séguin C.	-	Haematologic factors potentially implicated in the pathophysiology of avascular necrosis of the femoral head (AVN): hypercoagulability as a cause of AVN
Sehgal L. R.	-	Report from the studies on prevention: Extended travel
	-	Thrombosis prophylaxis following total hip replacement
	-	Cost-effectiveness of venous thromboembolism prophylaxis after total hip replacement
Sehgal L. R.	-	Use of umbilical cord vein in an in vitro perfusion model to study blood-borne metastasis
Seidinger D.	-	Abciximab reduces monocyte tissue factor after carotid angioplasty and stenting: role of monocyte platelet cross talk in cerebral microembolization
	-	Abciximab reduces monocyte tissue factor after carotid angioplasty and stenting: role of monocyte platelet cross talk in cerebral microembolization
	-	High dose of atorvastatin does not effect levels of plasma tissue factor in patients with coronary artery disease
Seifert V.	-	Increased thrombophilic abnormalities in patients with cranial dural arteriovenous fistulae
	-	The risk of postoperative hemorrhage after intracranial surgery following early Nadroparin administration – results of a prospective study
	-	The administration of recombinant coagulation factor VIIa (rFVIIa) during neurosurgical procedures
Seifried E.	-	Analysis of mRNA in a panel of hemophilia A patients with no detectable mutation in the coding regions of the factor VIII gene
	-	Mutations in genes of the gamma-glutamyl carboxylase and the vitamin K epoxidase reductase complex are responsible for the phenotype of hereditary combined deficiency of vitamin K-dependent clotting factors
	-	Detection of lupus anticoagulant: development of a new precise, sensitive and specific aPTT-based assay
	-	Mutation profiling in congenital FXIIIA deficiency: detection of 6 novel mutations
Seifried E.	-	Intracellular trafficking of native, full-length, and B-domain-deleted coagulation factor VIII (FVIII) in mammalian cells
	-	Developing hematopoietic stem cells as targets for gene therapy of hemophilia A
Seifried E.	-	Genetic profiling of 20 patients with FVII deficiency by dHPLC and sequence analysis: detection of 7 novel mutations
	-	Genetic mechanisms underlying the clinical manifestation of hemophilia A in females
Seitz R.	-	Coagulation factor V in normal bronchial epithelial and lung cancer cells
	-	Intracellular signaling in human endothelial cells induced by the hyaluronan-binding protease
	-	Mutation profiling in congenital FXIIIA deficiency: detection of 6 novel mutations
	-	The thrombogenic agent in prothrombin complex concentrates (PCC): Identification of elevated levels of prothrombin as the major cause
	-	Mechanisms involved in the differential regulation of endothelial cells and lung fibroblasts by the hyaluronan-binding protease
	-	A multicenter study on the potency estimation of ReFacto
Seki J.	-	Effect of ADP P2Y12 receptor inhibition on thrombosis and bleeding measured using guinea pigs
	-	Impaired flow-mediated vasodilation in vivo and reduced shear-induced platelet reactivity in vitro in response to nitric oxide in prothrombotic, stroke-prone spontaneously hypertensive rats
Seki T.	-	Regulation of plasminogen activation at the surfaces of mouse hepatocyte
	-	Transcription of plasminogen gene in mouse hepatocytes is regulated by cellular density
Sekino T.	-	Usefulness of the prothrombin level measured by the carinactivase-1 method as the parameter of the coagulation activity during chronic warfarin therapy
Sekiya F.	-	GPVI- and GPIb/V/IX-induce tyrosine phosphorylation at Syk and PLCg2 at distinct sites
Seknadji P.	-	The Asp299Gly polymorphism of Toll-like receptor 4 as a genetic risk factor for acute coronary events
Sela B.-A.	-	Prevalence of circulating procoagulant microparticles in allogeneic stem cell transplantation (alloSCT) for hemato-oncological malignancies
Seldon M.	-	Using ETP to predict which factor V Leiden heterozygotes will suffer from venous thrombo-embolism
Selhub J.	-	Low vitamin B6, markers of inflammation, and coronary artery disease
Seligsohn U.	-	The molecular basis of Glanzmann thrombasthenia in Arabs
	-	Aging of ancestral mutations causing factor VII deficiency and Dubin–Johnson syndrome in Iranian and Moroccan Jews reflects ancient Jewish migrations
	-	The severely impaired thrombin generation in 5 patients with severe factor XI deficiency and inhibitors is corrected in vitro by recombinant factor VIIa
	-	Substitutions of conserved Gly193 (numbering according to chymotrypsin) located near the catalytic triad of factors VII, IX and XI yield dysfunctional proteins probably due to interference with accessibility of the respective substrates
	-	Cys61stop is the first identified nonsense mutation in the factor X gene causing severe factor X deficiency in 3 unrelated homozygotes of Arab origin
	-	Cone and plate(let) analyzer as a diagnostic tool in various types of thrombotic thrombocytopenic purpura and haemolytic uremic syndrome
Selim S.	-	Thrombin activatable fibrinolysis inhibitor in thrombophilic patients with activated protein C resistance
Seljeflot I.	-	Serum levels of the anti-inflammatory cytokine interleukin-10 are inversely associated with future events in patients with previous acute myocardial infarction
Seljeflot I.	-	The influence of warfarin on plasma levels of soluble tissue factor, prothrombin fragment 1 + 2 and D-dimer in patients after acute myocardial infarction
Seljeflot I.	-	Levels of soluble tissue factor are related to future clinical events in patients with previous myocardial infarction
Sella B. A.	-	Thrombophilia does not increase the risk for neonatal complications in preterm infants
Sellink E.	-	The small GTP-binding protein Ral is involved in cAMP-mediated release of VWF from endothelial cells
Semeraro N.	-	Increased procoagulant activity and impaired fibrinolytic potential in blood mononuclear cells after coronary angioplasty for stable or unstable angina
Semeraro N.	-	Increased TAFI-dependent anti-fibrinolytic effect associated with the presence of an anti-FV antibody in a patient with severe thrombophilia
	-	Identification of a dysfibrinogenemia characterized by marked resistance to fibrinolysis in an asymptomatic woman
	-	Hyperprothrombinemia is associated with enhanced TAFI-mediated inhibition of fibrinolysis
Semionova N. A.	-	Thrombolytic action of longolytin – product of low fungi Arthrobotrys longa in rabbit thrombosis model
Senis Y. A.	-	Characterization of novel platelet and procoagulant activities from Bothrops cotiara snake venom
	-	Variation of GPVI levels in platelets: relationship to platelet function at high shear
Senis Y.	-	Involvement of the p110d catalytic subunit of phosphatidylinositol 3-kinase in platelet spreading on fibrinogen
Sennett M.	-	Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto®) for surgical procedures in pediatric patients with severe hemophilia A
Sensel M.	-	Continuing clinical evaluation of an advanced category recombinant FVIII, antihemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM) in previously treated patients (PTPs)
Sensini A.	-	Chlamydia pneumoniae seropositivity is associated with increased inflammatory characteristics in atherosclerotic plaques
Seo K.	-	Quantitative transcript profiling and novel gene identification of vascular endothelial cell subtypes by serial analysis of gene expression (SAGE)
Serada M.	-	Phase I study of a novel recombinant human soluble thrombomodulin, ART-123
Seralena A.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Serban M.	-	Medical and surgical approach of pseudotumours and blood cysts in hemophiliacs without primary prophylactic replacement therapy
Serban M.	-	Evaluation of the rFVIIa efficacy in children's haemorrhages of different etiology
Seré K. M.	-	The regulation of thrombin formation by protein S in plasma in the absence of APC
Serebrjakova T. N.	-	Thrombolytic action of longolytin – product of low fungi Arthrobotrys longa in rabbit thrombosis model
Serebruany V.	-	Effects of clopidogrel-aspirin combination vs. aspirin alone on platelet aggregation and major receptor expression in patients with heart failure. For the plavix use for treatment of congestive heart failure (PLUTO-CHF) trial
	-	Platelet inhibition by valsartan and valeryl 4-hydroxy valsartan: a possible missing link to explain benefits of angiotensin II receptor blockers in patients after acute vascular events
Sergeeva E. V.	-	Laboratory (on base coagulological tests) it is latent proceeding hematogenous thrombophilias
	-	Dynamics of changes of parameters of a hemostasis in patients with sepsis
	-	Dynamics of changes of parameters of a hemostasis in patients with sepsis
Serino M. L.	-	The G>T point mutation (Val34Leu) in the Factor XIII-A subunit gene in venous leg ulcers
Serino G.	-	A case of multiorgan atherosclerotic disease in patient affected by hyperhomocystinemia with multiple heterozygous mutations
Serra J.	-	Evaluation of HaemosIL HS-CRP. A new latex immunoassay to quantitatively determine C-Reactive Protein (CRP) in citrated plasma, totally automated on coagulation analysers
Serro F.	-	Temporary discontinuation of oral anti-coagulants in oncologic patients with mechanical heart valves
Sersa I.	-	Shear rate of plasma flow and fibrin specificity of thrombolytic agent promote thrombolysis of nonretracted and retracted whole blood clots – a MRI study in vitro
Serviddio M. R.	-	Cerebral sinovenous thrombosis (SVT) in children: a prospective 10-year registry in Argentina
	-	Venous thromboembolism (VTE) in children: A prospective 10-year registry in Argentina
	-	Arterial ischemic stroke (AIS) in children: a prospective 10-year registry in Argentina
Seshadri N.	-	Safety and efficacy of using Low-Molecular-Weight Heparins to bridge patients on long-term warfarin
Sesti C.	-	CD39 ecto-nucleotidase activity (metabolizing ATP to ADP to AMP) constitutes a homeostatic mechanism for control of platelet reactivity, depending on the ratio of ADPase to ATPase activity. Results from patients with coronary artery disease
Sestini I.	-	Emerging prognostic factors in ischemic heart disease
	-	High plasma homocysteine concentrations in cerebrovascular patients with Fabry disease
Sethi M.	-	Elevated factor VIII: a possible link between periodontal disease and acute coronary syndrome
Setiati T. E.	-	Endothelial cell and monocyte-derived microparticles in severe dengue virus infections
	-	Coagulation abnormalities in dengue virus infections: more common than currently perceived?
Setiawan H.	-	Coagulation abnormalities in dengue virus infections: more common than currently perceived?
Setty Y.	-	Tissue factor in sickle cell disease: Source and potential mediators
Setty B.	-	A novel endothelial receptor involved in red cell-endothelial cell adhesion
Seuc A.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Seyfert U. T.	-	On the role of platelets, and homocysteine in thrombotic patients, healthy controls and mutant carriers of methylentetrahydrofolate reductase (‘MTHFR’) (C677T)
	-	Thrombophilia – from the roots to the base of evidence. Preliminary results on platelet function and rheologic parameters and the necessity of prospective multicentre cohort trials
	-	Evidence of C677T methylentetrahydrofolate reductase (‘MTHFR’) and hyperhomocysteinemia (HH) – causal or casual coexisting risk factors?
Sezgin Y.	-	Erythrocytic membrane proteins in sickle cell anemia in crisis and steady state
Sfiraki N.	-	Left adrenal hemorrhage with intravascular coagulation- case report
Sfiridaki K.	-	Obesity and coagulation. Is there any correlation?
Sfiridaki K.	-	Levels of plasma tissue activator plasminogen (tPA)- A useful marker in the differential diagnosis of chest pain (marker of plaque destabilization)
	-	Correlation between SVCAM, SICAM plasma levels, the outcome of treadmill test and the systolic function of left ventricular (LV) in patients with coronary artery disease
	-	Correlation SVCAM, SICAM plasma levels with the outcome of treadmill test and with attitudinal factors for coronary artery disease in patients without previous history of ischemic heart disease
Sfiridaki K.	-	Inflammatory factors in patients with acute coronary syndromes. Is there any fluctuation with smoking or cholesterol levels?
	-	Is there an hypercoagulable state after treadmill exercise in patients with atrial fibrillation?
	-	Smoking and abnormalities of coagulation-fibrinolysis in patients with coronary heart disease
Sfyraki N.	-	Comparison and diagnostic value of two different D-dimer methods in the clinical laboratory
Sguibnev A. V.	-	Kinetics of factor XI activation by thrombin in the presence of activated platelets: a mathematical model, based on the Botts and Morales mechanism
Shaban A.	-	Thrombocytopenia in HIV-infected patients, a report from HIV/AIDS Counseling and Care Center in Kermanshah, Iran
Shah N. R.	-	A systematic review of the accuracy of ultrasound in the diagnosis of asymptomatic deep venous thrombosis: preliminary results
Shaji R. V.	-	Three novel missense mutations in the b-propeller domains of GPIIb (aIIb integrin) among three unrelated patients with Glanzmann thrombasthenia from southern India
	-	Factor IX gene deletions are a frequent cause of hemophilia B in India
	-	Administration of gentamicin does not increase factor levels in severe hemophilia-B due to premature termination codons
Shalhoub J.	-	Anti-angiogenic activity of heparins and anti-thrombin
Shamayeva G.	-	Correlation of the serum ferritin (SF) levels with cholesterol and body mass index (BMI) in patients with advanced atherosclerosis
Shamseddine A.	-	High prevalence of prothrombin G20210A mutation among patients with deep venous thrombosis in Lebanon
Shanbrom E.	-	Total fibrin ‘super glue’ components from human plasma: a new blood banking procedure
Shanbrom E.	-	Pathogen inactivation by ‘cascade iodination’
	-	Revisiting human plasma-derived factor VIII
Shand B. L.	-	Plasma adiponectin and the metabolic syndrome
Shang D.	-	Development of bifunctional inhibitors of both platelet aggregation and factor Xa
	-	The influence of the substitution of arginine within the RGD tripeptide motif of dendroaspin on its activity as a potent inhibitor of platelet aggregation and cell adhesion
Shanley C.	-	Safety considerations of Enoxaparin as an alternative to oral anti-coagulants in high risk cardioembolic patients with a programed surgical procedure. SWITCH trial
	-	High levels of factors VIII, IX and XI in patients with a thromboembolic event
Shao B.	-	Soluble platelet GPV: a new marker of thrombosis status
Shapiro A.	-	Clinical evaluation of an advanced category recombinant FVIII, anti-hemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM) in pediatric previously treated patients (PTPs)
Shapiro A.	-	Continuing clinical evaluation of an advanced category recombinant FVIII, antihemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM) in previously treated patients (PTPs)
Sharathkumar A.	-	Use of low molecular weight heparin in children with thromboembolic events; predictors for bleeding and recurrence on therapy
Shariat-Madar Z.	-	Mapping the interaction between uPAR and high molecular weight kininogen
Shariat-Madar Z.	-	Recombinant prolylcarboxypeptidase activates plasma prekallikrein
Sharifiyan R. A.	-	Analysis of 100 Iranian patients with factor XIII (sub unit A) deficiency
Sharkey R.	-	A transient factor V inhibitor associated with vasculitis
Sharkova T. S.	-	Thrombolytic action of longolytin – product of low fungi Arthrobotrys longa in rabbit thrombosis model
Sharma L.	-	The cytoplasmic domain of tissue factor plays an important role in innate and adaptive immunity
	-	The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia
Sharma A.	-	Local and clinical factors are the likely cause of venous thrombosis in lower limb arthroplasty
Sharma S.	-	Clinicopathological findings and response to treatment in childhood and adult immune thrombocytopenic purpura
Sharp P.	-	The development of an automated, real time, oral anticoagulant dosing module to enhance traditional computerized decision support software (CDSS)
Sharples R.	-	The safety and efficacy of beriplex P/N for rapid warfarin reversal in major hemorrhage – a prospective evaluation of a regional protocol
Sharrett A. R.	-	Intracellular adhesion molecule-1 is associated with cardiovascular disease in elderly men and women
Shashaani T.	-	Prevalence of activated protein C – resistance (APC-R) in patients with thromboembolic events: the first report from Iran
Shattil S.	-	The scaffold function of b3 integrins regulates integrin signaling
Shattil S.	-	Bleeding phenotype and decreased viability in rap1b knockout mice
Shaw G. D.	-	Role of platelet-leukocyte–endothelium interactions in neointimal hyperplasia
Shaw M.	-	The use of three hemophilia A mouse models to illustrate strain-specific differences in immune responses to FVIII protein replacement via protein infusion or adenoviral gene therapy
Shearer M.	-	Multivariate investigation of determinants of oral anti-coagulant stability
Shedarowich K.	-	A proposed mechanism for reduced bleeding of direct thrombin inhibitors as compared to heparin as measured by thromboelastography
Sheehan J. P.	-	Expression of recombinant human gla-domainless factor X (gdFX) in the baculovirus: assessing substrate recognition by the intrinsic tenase complex
	-	Binding at two distinct exosites is required for activation of prothrombin by prothrombinase
Sheffield W. P.	-	Alterations to the Leu444 (P1) residue of heparin cofactor II: Similarities and dissimilarities to HCII (L444R)
Sheffield W. P.	-	Effects of full and partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II on the inhibition of thrombin and activated protein C
Sheffield W. P.	-	Carboxy-terminal mutations render heparin cofactor II more susceptible to secretory impairment than equivalent mutations in antithrombin
Sheikh S.	-	Conditioning of endothelial cells by different levels of fluid shear stress modulates their ability to induce each stage of neutrophil adhesion and migration in response to TNF-a but not IL1-b
Sheikh M.	-	Reteplase and direct thrombin inhibitors: concurrent use for acute thrombotic events in patients with heparin-induced thrombocytopenia
Sheli N.	-	The relationship between risk factors for premature vascular disease in systemic lupus erythematosis (SLE) with secondary anti-phospholipid syndrome (APS)
	-	Risk factors for carotid artery plaque formation in premenopausal women with systemic lupus erythematosus
Shelton D. K.	-	Incidental pulmonary embolism in patients with cancer
Shemirani A. H.	-	Activation of factor XIII in whole plasma: the influence of Val34Leu polymorphism
Shen I.	-	Report of argatroban infusions for heparin-induced thrombocytopenia (HIT) diagnosed by functional assay in 2 congenital cardiac surgery patients, a neonate and a 5-month old
Shen M. C.	-	A G-to-A mutation at -33 position in the promoter region of thrombomodulin gene and non-O blood group are associated with idiopathic venous thromboembolism: Taiwan Thrombophilia Study
Shen G. X.	-	Statin regulation of extrinsic thrombin generation
Shen M.	-	Novel mutations in the factor X gene of a Taiwanese factor X-deficient patient
Shen M. I.	-	A novel anti-oxidant, octyl caffeate, suppresses LPS/IFN-g-induced iNOS gene expression in rat aortic smooth muscle cells
Shen M. Y.	-	Inhibitory mechanisms of magnesium sulfate on platelet aggregation in in vitro and in vivo experiments
Shen I.	-	Heparin-induced thrombocytopenia (HIT) in neonates and very young children undergoing congenital cardiac surgery: a likely under-recognized complication with significant morbidity and mortality: report of 4 sequential cases
Shenkman B.	-	Monitoring the combined effect of integrilin, clopidogrel and aspirin in patients with myocardial infarction by Cone and Plate(let) Analyzer
	-	Cone and plate(let) analyzer as a diagnostic tool in various types of thrombotic thrombocytopenic purpura and haemolytic uremic syndrome
Shenoi J.	-	The three I hemophilic study: a comparative study of the morbidity pattern between Asian Indian, Iranian and Italian PWH
Shet A. S.	-	Venous thromboembolism is common but does not alter survival in glioblastoma multiforme
Shet A.	-	Successful liver transplantation in a hemophilia A patient with high titer factor VIII inhibitor
Shet A.S.	-	Sickle blood contains tissue factor positive microparticles derived from endothelial cells and monocytes
Sheth P. M.	-	Platelet-dependent alterations in fibrinolysis in the Quebec platelet disorder
Shetty S.	-	Burden of von Willebrand disease in India
	-	Diagnosis of neonatal alloimmune thrombocytopenic purpura (NAITP) by genotyping and human platelet antigen frequency in the Indian population
Shetty K. R.	-	Plasma tissue factor pathway inhibitor (TFPI) – A marker of severe coronary atherosclerosis
Shetty S.	-	Glanzmanns thrombasthenia in Indians – how different it is from other ethnic groups
Shetty S.	-	Direct detection of factor IX gene deletions in Indian hemphiliacs by multiplex PCR
Sheu J. R.	-	Comparison of the binding character of triflavin on resting and activated aIIbb3 integrin in human platelets by electron microscopy
	-	A novel anti-oxidant, octyl caffeate, suppresses LPS/IFN-g-induced iNOS gene expression in rat aortic smooth muscle cells
	-	Morphine-potentiated platelet aggregation in in vitro and platelet plug formation in in vivo experiments
Sheu J.	-	Inhibitory mechanisms of magnesium sulfate on platelet aggregation in in vitro and in vivo experiments
Shi C. X.	-	Treatment of severe canine hemophilia A by helper-dependent adenoviral-mediated gene therapy
Shi J.	-	Anticoagulant function of lactadherin correlates with phosphatidyl-L-serine specificity
Shi G. Y.	-	Enhanced anti-angiogenesis ability of human kringle 1–5 domain via altering glycosylation sites and lysine binding properties
Shi J.	-	A novel point mutation in the transmembrane domain of the platelet glycoprotein IX associated with bernard–soulier syndrome
Shi G. Y.	-	Modulation of thrombin signaling by internalization of thrombin and thrombomodulin complex
Shi B.	-	Soluble platelet GPV: a new marker of thrombosis status
Shi C. X.	-	The use of three hemophilia A mouse models to illustrate strain-specific differences in immune responses to FVIII protein replacement via protein infusion or adenoviral gene therapy
Shi J.	-	Limited exposure of phosphatidylserine on stimulated platelets is necessary for procoagulant activity and provides binding sites for lactadherin
Shiach C.	-	European concerted action on anti-coagulation (ECAA). reliability of International Normalized Ratios (INR) from CoaguChek mini and TAS PT-NC whole blood point-of-care test monitor systems
	-	European concerted action on anti-coagulation (ECAA). Correction of displayed INR on two point-of-care test (POCT) whole blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent International Sensitivity Index (ISI) calibration
	-	European action on anti-coagulation – cost effectiveness of computer assisted anti-coagulant dosage
Shibamiya A.	-	Degradation pathway of the naturally occurring mutants of protein C and plasmin inhibitor by the proteasome
Shibano T.	-	Genetic analysis of hereditary factor X deficiency in a French patient of Sri Lanka ancestry: in vitro expression study identified Gly366Ser substitution as the molecular basis of the dysfunctional factor X
Shibata T.	-	A novel ELISA method for soluble fibrinogen and fibronectin complexes (FG–FN) in normal adult's and DIS patient's plasma
Shibata N.	-	Effect of KFA-1982, a new orally active factor Xa inhibitor, in a rabbit venous thrombosis model
Shikamoto Y.	-	Effect of Mg(II) ion on the interaction of factor IX with phospholipid membrane
Shiku H.	-	Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with DIC
Shiku H. S.	-	Frequency of biphasic transmittance waveform in the APTT coagulation assay in the patients with underlying diseases of DIC
Shiku H.	-	Measurement of tissue factor messenger RNA levels in leukocytes from patients with underlying diseases of disseminated intravascular coagulation
Shiller E. E.	-	The experience of treatment of children with hemostasis system pathology treatment with recombinant factor VII NovoSeven
Shim K.	-	Dominant negative anticoagulant effects of mouse recombinant meizothrombin precursor R157A/R268A delay thrombus formation in a mouse injured carotid artery
Shima M.	-	The utilities of recalcification time clot wave-form in the evaluation of the hemostatic effect of factor VIIa in hemophilia A and B
Shima M.	-	M-thrombin (Tris-coupled thrombin) is a novel potent agonist of platelet activation with minimum effect on clot formation
	-	Population-based study of acquired hemophilia A
	-	Characterization of anti-factor VIII antibodies using Time-Resolved Fluoroimmunoassay
	-	Hemophilia A gene therapy using the third-generation lentiviral vector – Mouse model
	-	Factor V C2 domain contains major binding site for thrombin
	-	The hemostatic effectiveness of regular infusions of factor VIII concentrates in hemophilia A patients with high responder inhibitors
Shimizu H.	-	Phase I study of a novel recombinant human soluble thrombomodulin, ART-123
Shimizu K.	-	Affinity-trap protease reactor for single-step conversion/purification of angiostatin from human plasma
Shimoji T.	-	Anti-platelet and anti-thrombotic effects of CS-747, a novel P2Y12 receptor antagonist, in combination with aspirin
Shimokawa T.	-	Aging and obesity augment the stress-induced expression of tissue factor gene in the mouse
Shin H.	-	The anti-platelet activity of J78 is mediated mainly by inhibition of arachidonic acid metabolism
Shin I. S.	-	A collaborative study to establish a Korean standard for factor VIII : C concentrate
	-	A collaborative study to establish a Korea National Biological Standard for antithrombin III concentrate
Shingo Y.	-	ADP regulates the expressions of tissue-type plasminogen activator (tPA) and plasminogen activator inhibitor-1(PAI-1) in rat aortic endothelial cells
Shinya A.	-	Sphingosine 1-phosphate-related metabolism in the blood
Shinzo K.	-	ADP regulates the expressions of tissue-type plasminogen activator (tPA) and plasminogen activator inhibitor-1(PAI-1) in rat aortic endothelial cells
Shiozaki Y.	-	The effect of direct FXa inhibitor and direct thrombin inhibitor on TF induced DIC and venous thrombosis models in anesthetized rat – thrombin inhibitor enhance the platelet consumption in DIC model
Shiraga M.	-	Analysis of Arg-Gly-Asp contact sites in the av subunit of integrin avb3 employing single amino acid mutations
	-	Interaction of CD47 with SHPS-1 negatively regulates platelet function
	-	Demonstration of activation of integrin aIIbb3 by inside-out signaling in a megakaryocytic cell line, CMK
Shirahata A.	-	Present status of hemorrhargic disease of newborn and young infants resulting from vitamin K deficiency in Japan
Shirakawa Y.	-	Present status of hemorrhargic disease of newborn and young infants resulting from vitamin K deficiency in Japan
Shirley K.	-	The rate of thrombus resolution following treatment of DVT is related to the site and the precipitating cause of thrombosis
Shitikova A. S.	-	Increased platelet activation in hyperhomocysteinemic patients
	-	The prevalence of polymorphism PlA2 of platelet glycoprotein IIb-IIIa in the population of North-west Russia
Shlebak A.	-	Improving the quality of INR determination in the anticoagulation clinic
Shmeleva V. M.	-	Venous thromboembolism in North-western Russia and genetic polymorphisms
	-	Increased platelet activation in hyperhomocysteinemic patients
Shoji T. S.	-	Recombinant sendai virus-mediated intramuscular gene transfer of FGF-2 restores collateral blood perfusion of chronically ischemic rabbit hind limb, and inhibits neointimal hyperplasia of autologous femoral vein grafts
Shorey N.	-	Diagnostic utility of Simplify d-dimer – a new d-dimer test for patients with suspected venous thromboembolism
Shrier I.	-	Specific and nonspecific antiphospholipid antibodies in recurrent fetal loss: a meta-analysis
	-	Resource utilization and loss of productivity during the 4 months following a diagnosis of deep venous thrombosis
Shrimpton C. N.	-	Tissue factor-bearing microparticles arise from monocyte lipid rafts and can fuse with activated platelets, consolidating all of the membrane-bound coagulation reactions on the platelet surface
Shroff M.	-	Low molecular weight heparin therapy in neonatal cerebral sinovenous thrombosis: a consecutive cohort study
Shubina T.	-	The influence of treatment with low molecular weight heparins (dalteparin, nadroparin) on the clinical course and hemostasis activation markers in patients with unstable angina
	-	The influence of exercise and stress on markers of activation of coagulation and fibrinolysis in young postinfarction patients
Shulutko E.	-	Use of recombinant activated factor VII (rFVIIa) for management of postoperative bleeding in patients with idiopathic thrombocytopenic purpura (ITP)
Shuman H.	-	Intermolecular forces of individual aIIbb3-fibrinogen and aVb3–osteopontin interactions on platelets
Shuyan Z.	-	Simultaneous occurrence of lupus anticoagulant and factor VIII inhibitors in hyperththyroisis
Siali R.	-	Extracorporeal adsorption of Factor VIII antibodies on randomly functionalized polystyrene resins
Siboni S.	-	A study of 130 Italian patients on anti-coagulant treatment: how variant alleles of gene CYP2C9 influence requirement dose of warfarin during the induction period of treatment
Sichler K.	-	The active conformations of Factor VIIa and Factor IXa: biochemical, biophysical, chemical and crystallographic studies
Sicker T.	-	Mutation profiling in congenital FXIIIA deficiency: detection of 6 novel mutations
Siddiqui F. A.	-	Functional anti-heparin-PF4 antibody-mediated platelet–endothelial cell interactions: modulation of tissue factor activity involved in the HIT pathogenesis
Siddiqui F. A.	-	Tissue factor is present in platelet-derived microparticles from healthy donors
Siddiqui T. F.	-	Tissue factor is present in platelet-derived microparticles from healthy donors
Siddiqui F.	-	Platelet purified vascular endothelial growth factor-165 enhances tumor cell tissue factor expression and procoagulant activity
Siddiqui T. F.	-	Platelet purified vascular endothelial growth factor-165 enhances tumor cell tissue factor expression and procoagulant activity
Siddiqui F.	-	Haemoglobin induces the production and release of matrix metalloproteinase-9 from human malignant cells
Siddiqui T. F.	-	Haemoglobin induces the production and release of matrix metalloproteinase-9 from human malignant cells
Sie P.	-	Shedding of active tissue factor (TF) by rat aortic smooth muscle cells (SMCs) undergoing apoptosis
Sieder A.	-	High prevalence of aspirin resistance in patients with acute coronary syndromes
Siegbahn A.	-	A sensitive method for tissue factor mRNA quantitation
	-	The activation of inflammation and coagulation by different heparin surfaces
	-	Formation of the catalytically active FVIIa/tissue factor complex leads to enhanced PDGF-BB-stimulated chemotaxis and IL-8 release in monocytes
Siegel R. J.	-	Ultrasound improves myocardial perfusion in a canine model of myocardial infarction
Siegemund A.	-	Extrinsic pathway function, thrombin generation potential and perioperative blood loss in CABG surgery
Siegemund A.	-	GP IIb-IIIa antagonists and thrombin generation
Siegemund T.	-	GP IIb-IIIa antagonists and thrombin generation
Siegemund A.	-	Platelet mediated thrombin generation depends on F VIII and Factor IX in a complex way: evidences for the Cell-based model of hemostasis
Siegemund T.	-	Platelet mediated thrombin generation depends on F VIII and Factor IX in a complex way: evidences for the Cell-based model of hemostasis
Siegemund A.	-	The influence of the prothrombin mutation 20210 GA and the level of prothrombin on the thrombin generation
Siegemund T.	-	The influence of the prothrombin mutation 20210 GA and the level of prothrombin on the thrombin generation
Siegenthaler M. P.	-	The Jarvik 2000 artificial heart does not affect the activation status of platelets
Siegert G.	-	Correlation of parameters characterizing healthy newborns with cord blood concentration of thrombin activatable fibrinolysis inhibitor (TAFI)
Siegling S.	-	Expression of wild type tissue factor pathway inhibitor (TFPI) and the first natural TFPI mutant ([P151L]) in insect and mammalian cells
	-	Quantification of tissue factor pathway inhibitor (TFPI) in human seminal plasma and in human ovarian follicular fluid
Siegmund B.	-	Prophylactic treatment of afibrinogenemia with the fibrinogen concentrate Haemocomplettan®
Siegmund B.	-	The development of inhibitors directed against factor VIII after continuous infusion of factor VIII concentrates in patients with hemophilia A
Siegmund A.	-	Investigation of plasma related influence factors of a new protein S activity assay (protein S Ac®)
Siemensen M.	-	Monitoring platelet concentrates (PCs) during storage by functional and immunological tests
Siemiatkowski A.	-	A prospective analysis of hemostasis in systemic inflammatory response syndrome (SIRS) with acute renal failure
	-	Different pattern of hemostatic abnormalities in infectious and noninfectious systemic inflammatory response syndrome (SIRS)
Siemieniak D. R.	-	The factor V Leiden mutation results in the in vivo loss of a critical FV anticoagulant function
	-	A sensitized ENU mutagenesis screen for dominant genetic modifiers of thrombosis in the factor V Leiden mouse
Siess W.	-	Analysis of the Rho-kinase/LIM-kinase/cofilin signaling pathway in activated platelets
Siest G.	-	Phenotypic sensitivity to activated protein C in healthy families: importance of genetic components and environmental factors in the Stanislas Cohort
Sigal Y.	-	Lipid Phosphate Phosphatase 1 (LPP1) regulates lysophosphatidic acid signaling in platelets
Sigounas G.	-	Plasma markers of hemostatic activation in patients with cancer and deep venous thrombosis
	-	Plasma hemostatic markers in patients with malignancy: correlation with tumor progression and response to treatment
Siguret V.	-	Influence of cytochrome P450 2C9 polymorphisms on warfarin maintenance dose in very elderly patients
Siguret V.	-	Heparin releasable TFPI Is not depleted after repeated injections of tinzaparin at therapeutic dose for up to 30 days
Siigur E.	-	Vipera lebetina factor X activating enzyme – cloning and sequencing
Siigur J.	-	Vipera lebetina factor X activating enzyme – cloning and sequencing
Siimes M.	-	Hand computer and Internet for collection and presentation of patient diary data in a Nordic clinical multicenter safety surveillance study of ReFacto®
Sikiotis K.	-	Thromboprophylaxis in laparoscopic cholecystectomy: identification of a high-risk group of patients
Silaruks S.	-	Detection of the factor XIIIA Val34Leu polymorphism in Thais
Silingardi M.	-	Clinical and laboratoristic performance evaluation of three point-of-care devices for INR determination (Coagucheck, ProTime, Harmony)
Silingardi M.	-	Hyperhomocysteinemia and other thrombophilic factors in Italian patients with inflammatory bowel disease
Silingardi M.	-	Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
	-	1286 prospective consecutive cases of venous thromboembolic disease at the single venous thromboembolic Unit of Reggio Emilia
	-	Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
Siljander P. R.	-	Functional significance of single-nucleotide polymorphisms in the glycoprotein VI gene
Siljander P. R.-M.	-	Interplay of glycoprotein Iba, integrin a2b1 and glycoprotein VI is required for human thrombus formation under flow
Siljanovski N. S.	-	Acquired postpartum hemophilia: report of a case
Silva C. R. S. S.	-	Comparative analysis of methods for detection of Activated Protein C resistance: an analysis of 755 consecutive patients
Silva L.	-	The use of the rotational thrombelastograph (ROTEG) in the quantification of the ‘lytic state’ during thrombolytic therapy: a comparative analysis in the subhuman primate
Silva C. S. S.	-	Inherited prothrombotic risk factors in a Brazilian cohort with CVT
Silva R.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Silveira P. A. A.	-	Successful use of Arixtra® in a patient with PNH, Budd–Chiari syndrome and HIT
Silveira A.	-	A relationship between SHBG and APCr during OC treatment
Silver L.	-	‘Aspirin resistance’ detected by high shear platelet function testing within the pilot phase of the Oxford Vascular Study (OXVASC)
	-	Markers of hemostatic activation and protein Z in acute stroke and myocardial infarction: a community based pilot study
Silverman T.	-	Pulmonary embolism in liver transplant setting associated with the use of solvent detergent plasma
Silvestrini R.	-	Laboratory assessment of acquired thrombophilia: current and past experience in Australasia with lupus anticoagulant (LA) and anti-cardiolipin antibody (ACA) testing
Sim Y.	-	Carboxypeptidase U (TAFIa) prevents fibrinolysis from proceeding into the propagation phase through a threshold-dependent mechanism
Simionescu M.	-	Effects of enoxaparin on high glucose induced activation of human endothelial cells
Simioni P.	-	The incidence of venous thromboembolism in carriers of single identified prothrombin G20210A: a retrospective cohort study
Simioni P.	-	Anti-thrombin III levels in cynomolgus monkey recipients of a life-supporting porcine renal xenograft
Simioni P.	-	Factor V Gly2112Asp, a C2-domain variant, is associated with severe deficiency and a bleeding tendency
	-	Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study
	-	Correlation between internal carotid artery stenosis and hematological risk factors for thrombosis (CAST study): final results
Simioni P.	-	Levels of anti-thrombin III activity in the plasma of cynomolgus monkeys after administration of recombinant human anti-thrombin III
Simioni M.	-	Association between fibrinogen levels and fibrinogen G-455 A polymorphism and preclinical atherosclerosis in the general population
Simioni P.	-	Incidence of recurrent ischemic stroke in children with coagulation abnormalities
	-	Increased TAFI-dependent anti-fibrinolytic effect associated with the presence of an anti-FV antibody in a patient with severe thrombophilia
	-	The incidence of venous thromboembolism in double-heterozygous carriers of antithrombin, protein C and protein S deficiency and HR2 haplotype
	-	The incidence of venous thromboembolism in homozygous or double heterozygous carriers of the factor V Leiden mutation, prothrombin 20210 A mutation and HR2 aplotype: interim report
	-	The long-term clinical course of acute deep vein thrombosis of the arm: a prospective cohort study
	-	Impaired interaction of protein C Gla domain variants with the endothelial cell protein C receptor (EPCR)
Simmonds R. E.	-	Impaired interaction of protein C Gla domain variants with the endothelial cell protein C receptor (EPCR)
	-	Human endothelial cell protein C receptor (EPCR) expression: role of proximal and distal 5'-gene regulatory elements
	-	High-level in vitro expression of protein S after modifications of protein S cDNA
	-	PROSIT: functional analysis of identified PROS1gene mutations
Simón R.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Simon R.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Simoncini S.	-	Activation of p38 MAPK promotes an endothelial adhesive phenotype in response to anti-phospholipid antibodies
Simoneau G.	-	d-dimer levels: a prognostic value in patients with chronic atrial fibrillation
	-	A comparative pharmacodynamic study of anti-Xa activity to evaluate the accumulation effect of Tinzaparin and Enoxaparin given at prophylactic dose over 8 days in elderly patients with impaired renal function
	-	Early prediction of the sensitivity of warfarin in elderly patients by the fall in factor VII
	-	Oral anti-coagulation in elderly patients in clinical practice: 187 patients
Simonet S.	-	Influence of selective nonpeptide PAR-1 and PAR-4 antagonists on thrombin-induced aggregation of human platelets
Simonnet V.	-	In terms of clinical impact, thromboplastins with an ISI close to 1 yield better results than thromboplastins with an ISI close to 2, in an external quality control campaign
Simpson J. C.	-	Intracellular trafficking of native, full-length, and B-domain-deleted coagulation factor VIII (FVIII) in mammalian cells
Simpson D. F.	-	Increased thrombin–anti-thrombin III levels in pre-eclampsia and disseminated intravascular coagulation
Sinauridze E. I.	-	Comparative study of the effect of recombinant factor VIIa on clot growth and thrombin generation in normal and hemophilia A plasma in vitro
Singer H.	-	Application of human factor XIII in children with massive pleural effusions after open heart surgery
Singh G.	-	Fibrinolysis within the procoagulant VX-2 tumor of rabbit lungs in vivo: Anti-angiogenic behavior of fibrin(ogen) degradation products
Singh R.	-	Prediction and prevention of thrombosis during pregnancy and oestrogen use
Singh R. K.	-	Thrombotic potential may be increased in healthy individuals with a two-generation family history of premature myocardial infarction
Sinha D.	-	Binding to a negatively charged surface alters the conformation of factor XIa
Sinha U.	-	Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis
Sinigaglia F.	-	Activation of p38 MAP kinase in human platelets stimulated by von Willebrand factor
Sinno S.	-	Activation of neutrophils by antibodies generated in heparin-induced thrombocytopenia
Sinzinger H.	-	Biochemical fibrinogen modification and atherogenesis
Sioufi J.	-	Laboratory diagnosis of von Willebrand Disorder: current and past practice in Australasia
Sioulis A.	-	Thrombophilic tendency in patients with chronic renal disease submitted to regular dialysis
Sir Bell P. R. F.	-	The anti-platelet effect of aspirin is reduced following administration of heparin during carotid endarterectomy
Sirachainan N.	-	Cost-effectiveness in establishing carrier detection and prenatal diagnosis services in a developing country with limited health resources
	-	Genetic modifications that increase factor VIII secretion in vitro and in vivo
Siraganian R. P.	-	GPVI- and GPIb/V/IX-induce tyrosine phosphorylation at Syk and PLCg2 at distinct sites
Siragusa S.	-	Objective assessment of deep vein thrombosis and pulmonary embolism can be deferred without increased risk of thrombosis: a practical approach based on the pretest clinical model, d-dimer and the use of low molecular weight heparins
	-	Coagulation and complement inhibitors levels predict outcome in patients with severe sepsis
	-	Chemotherapy-induced activation of hemostasis: the role of d-dimer
Sirgausa S.	-	Optimal duration of oral anti-coagulant therapy after the first episode of deep vein thrombosis of the lower limbs: a randomized study based on the recanalization of the veins detected by ultrasonography
Sironi L.	-	Pentoxifylline prevents spontaneous brain ischemia in stroke-prone rats
Sironi L.	-	Post-treatment of rats with simvastatin affords brain protection after focal ischemia as assessed by magnetic resonance imaging
Sirotkina O. V.	-	Molecular risk factors are important causes for the thrombosis in childhood
Sitzer M.	-	Lupus anticoagulant in systemic lupus erythematodes as risk factor for cryptogenic stroke
Siu A.	-	The impact of intravenous heparin administration on duration of hospitalization
Sizonenko V.	-	Disseminated intravascular coagulation in surgary
Sjörin E.	-	Why does the mutation G 17736A, Val 107 Val (silent), in the FIX gene cause hemophilia B in five Swedish families?
Skaer T. L.	-	Economic modeling of full-length anti-hemophilic factor (recombinant), plasma/albumin-free method (rAHF-PFM), vs. B-domain deleted rFVIII (BDDrFVIII) in previously treated patients (PTPs) with hemophilia A
	-	Economic evaluation of anti-D immunoglobulin in the treatment of immune thrombocytopenic purpura in adults in the United Kingdom
Skandalakis G.	-	Smoking and abnormalities of coagulation-fibrinolysis in patients with coronary heart disease
Skandalis A.	-	Early therapeutic splenectomy may reduce morbidity and management costs in selected resistant or relapsing cases of TTP/HUS
Skarnes W.	-	Dissociation of the JAM-1/avb3 complex followed by signaling through JAM-1 is key to the angiogenic response induced by bFGF: an explanation of the avb3 paradox
Skibo G. G.	-	Impairment of morphology and NO release in cultured endothelial cells from rabbit coronary vessels following total irradiation by external CO60
Skibowska A.	-	Changes in von Willebrand factor concentration and blood loss during cardiac surgery
Skilbecck C.	-	Sequential adhesion of platelets and then leukocytes from blood flowing over collagen in simple laminar and disturbed flow
Skopal J.	-	Thrombolytic therapy in acute ischemic stroke: same method, same team, different drug
Skrzeczynska J.	-	Sialic acid and lipid contents of low density lipoprotein in relation to platelet receptor activity
Skura A.	-	Suppression of thrombin generation and fibrinolysis in patients with rheumatoid arthritis treated with anti-TNFa monoclonal antibody (Infliximab)
Slaaf D. W.	-	In vivo involvement of ADP in thromboembolism through its receptors P2Y1 and P2Y12
Slaoui M.	-	Comparison of FVIII levels as venous thrombosis risk factor measured by a chromogenic and a coagulant assay
Slaoui M.	-	Acquired von Willebrand Syndrome: four cases associated with monoclonal gammopathy
Slavina N. N.	-	Clopidogrel in non-ST-elevation acute coronary syndrome: effect on parameters of fibrinolysis and blood coagulation
	-	Changes of hemostatic parameters in patients with non-ST elevation acute coronary syndrome treated with atorvastatin or pravastatin (randomized comparative study)
Slechtova M.	-	rFVIIa NovoSeven®– Hemostatic agent not only for hemophiliacs
	-	Risk of venous thromboembolism during pregnancy and puerperium in women with homozygous form of F V Leiden
Sleiman Zade Asfahani W.	-	Nine years experience at the AUB-MC vascular lab
Slezáková E.	-	Haemostyptics agents and blood platelet functions
Slichter S.	-	INTERCEPT platelets, treated to inactivate pathogens, maintain hemostasis in thrombocytopenic patients: results of the SPRINT trial
Slongo C.	-	Venice DVT
Slot J. W.	-	Co-localization of c-AMP-dependent PKA with eNOS in endothelial cell junctions: a clue for regulated NO production
Slusser J. P.	-	Familial segregation of venous thromboembolism
Smaltino V.	-	Preconceptional and gestational enoxaparin regimes adjusted to fertility program to prevent preclinical, embryonic and fetal loss in women with Recurrent Pregnancy Loss (RPL) and thrombophilia
Smaradottir A.	-	A case of acquired von Willebrand syndrome successfully treated with recombinant Factor VIIa during thyroidectomy
Smejkal P.	-	rFVIIa NovoSeven®– Hemostatic agent not only for hemophiliacs
Smethurst P. A.	-	Difference in binding of human and murine glycoprotein VI to collagen-related peptide and fibrillar collagen
Smethurst P. A.	-	Human glycoprotein VI: identification and blockade of the collagen-binding surface
Smethurst P. A.	-	Platelet glycoprotein VI has evolutionary conserved immunoglobulin domains, but a highly polymorphic stem and cytoplasmic domain
	-	Functional significance of single-nucleotide polymorphisms in the glycoprotein VI gene
	-	Interplay of glycoprotein Iba, integrin a2b1 and glycoprotein VI is required for human thrombus formation under flow
	-	The low frequency allele of glycoprotein VI raises the threshold for platelet activation by collagen and collagen-related peptides
	-	The use of synthetic triple helical peptides to define a recognition motif in collagen III for human platelet receptor, Glycoprotein VI
Smid W. M.	-	High-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in congenital coagulation disorders. A randomized, double-blind, placebo-controlled clinical trial
	-	Prolonged platelets preservation by transient metabolic suppression
Smilevska T. S.	-	Acquired postpartum hemophilia: report of a case
Smirnov M.	-	New chromogenic screening assay for detecting deficiencies in protein C and protein S
Smirnow M.	-	A new screening assay for abnormalities in the Protein C anticoagulant pathway
Smit J. W. A.	-	Subpopulations of tissue factor-exposing microparticles from platelets and T-cells colocalize leukocytic antigens in uncomplicated human type 2 diabetes
Smit C.	-	An evaluation of 30 years of hemophilia treatment in the Netherlands
Smit M. J.	-	Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner
Smit C.	-	Mortality of Dutch hemophilia patients, a prospective follow-up of 973 patients, 1992–2002
Smith V. C.	-	Severe factor VII deficiency caused by a new point mutation combined with a previously undetected gene deletion
Smith A.	-	Enhanced thrombus recanalization and resolution after vascular endothelial growth factor (VEGF) naked DNA gene transfer
Smith J.	-	Laboratory diagnosis of congenital thrombophilia: current and past practice in Australia
Smith E. Y.	-	Biphasic PTT waveform and adverse events in nonintensive care unit patients
Smith G.	-	Teicoplanin-dependent platelet antibodies as a cause of severe thrombocytopenia
Smith J. M.	-	A comparative study of new generation blood sampling tubes for thrombophilia investigations
Smith G.	-	The epitope of the CD109 monoclonal antibody 8A3 overlaps with the epitope of Gov antibodies: implications for Gov antibody detection
Smith O. P.	-	Thrombin causes an inflammatory cytokine response, which is inhibited by protein C, in both primary human monocytes and a monocyte (THP-1) cell line
Smith J.	-	Laboratory assessment of acquired thrombophilia: current and past experience in Australasia with lupus anticoagulant (LA) and anti-cardiolipin antibody (ACA) testing
Smith D. A. M.	-	Cross-linking of fibrin by factor XIII and its effect on fibrin structure/function
Smith O.	-	Protein C activation and possible use in different disease states - Protein C activation
Smith O. P.	-	NovoSeven does not produce an inflammatory reponse in a monocyte (THP-1) cell line or primary monocytes prestimulated with lipopolysaccharide
Smith E.Y. †	-	The effect of drotrecogin alfa (Xigris) on the biphasic PTT waveform in patients with sepsis
Smits P. H. M.	-	A two-stage thrombophilia screening protocol: more efficient use of laboratory tests
Smolina T. YU.	-	Activation of anti-coagulating system by gelatin introduction to animals
Smolina T. Y.	-	Influence of heparin-like plant component on fibrinolysis
Smorenburg S. M.	-	Malignancy and low-molecular weight-heparin therapy: the MALT trial
Smyth S. S.	-	P-Selectin deficiency results in impaired thrombus formation and frequent embolization in mouse model of carotid artery thrombosis
Smyth S. S.	-	Lipid Phosphate Phosphatase 1 (LPP1) regulates lysophosphatidic acid signaling in platelets
	-	b3-integrin deficiency and antibody-mediated b3-integrin inhibition have paradoxical effects on murine smooth muscle cell proliferation and the development of intimal hyperplasia after vascular injury
Smythe M. A.	-	Variability in antifactor Xa assay procedures
Smythe M.	-	A comparison of argatroban and lepirudin outcomes
Snaith M.	-	Risk factors for carotid artery plaque formation in premenopausal women with systemic lupus erythematosus
	-	The relationship between risk factors for premature vascular disease in systemic lupus erythematosis (SLE) with secondary anti-phospholipid syndrome (APS)
Snieder H.	-	Genetics of fibrin clot structure and interactions with factor XIII: a twin study
Snoeck D. P.	-	Subpopulations of tissue factor-exposing microparticles from platelets and T-cells colocalize leukocytic antigens in uncomplicated human type 2 diabetes
Sobas F.	-	Comparison of Clauss fibrinogen and fibrinogen measurement derived from aPTT and PT in diabetes mellitus and correlations with markers of glycemic equilibration
Sobocka M. B.	-	Phosphorylation and expression of the extracellular domain of the platelet adhesion receptor, F11R (a.k.a. junctional adhesion molecule, JAM-1)
	-	The platelet adhesion receptor, F11R (a.k.a. JAM-1), is critical for the initiation of plaque formation, thrombosis and atherosclerosis
	-	Genomic structure, organization and promoter analysis of the human F11 receptor (F11R) (junctional adhesion molecule-1, JAM-1)
Sobocki T.	-	Genomic structure, organization and promoter analysis of the human F11 receptor (F11R) (junctional adhesion molecule-1, JAM-1)
Sobocki T.	-	The platelet adhesion receptor, F11R (a.k.a. JAM-1), is critical for the initiation of plaque formation, thrombosis and atherosclerosis
	-	Phosphorylation and expression of the extracellular domain of the platelet adhesion receptor, F11R (a.k.a. junctional adhesion molecule, JAM-1)
Sobol A.	-	Is plasma homocysteine concentration different in diabetic and nondiabetic stroke patient up to the age of 55?
Sobrier M.-L.	-	Functional consequences of a factor VII gene donor splice site mutation causing a lethal factor VII deficiency: regulation in the splice site selection
Soccio M.	-	NAD(P)H oxidase C242T gene variations and cardiovascular protection
Sochanski M.	-	Platelet and inflammatory changes induced by angioplasty and brachytherapy
Soderberg M.	-	A comparison of spiral computed tomography and latex agglutination D-dimer assay in acute pulmonary embolism using pulmonary arteriography as Gold Standard
Söderberg M.	-	Spiral computed tomography has a higher sensitivity and specificity than d-dimer in the diagnosis of acute pulmonary embolism
Soejima K.	-	Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease
	-	Mechanism of decreased plasma von Willebrand Factor-cleaving metalloproteinase activity in patients with collagen vascular disease
	-	Mutations of ADAMTS13 gene in four Japanese families with Upshaw–Schulman syndrome
Soemantri A. G.	-	Endothelial cell and monocyte-derived microparticles in severe dengue virus infections
	-	Coagulation abnormalities in dengue virus infections: more common than currently perceived?
Soemod L.	-	Prolonged thromboprophylaxis with low molecular weight heparin (dalteparin) after major abdominal surgery: the FAME study
Sofi F.	-	Emerging prognostic factors in ischemic heart disease
Sofi F.	-	New risk factors for coronary artery disease: the endothelial nitric oxide synthase polymorphisms
Sofi F.	-	TAFI plasma levels are not increased in ischemic heart disease patients admitted to a coronary care unit
Sofi F.	-	Protein Z levels in acute coronary syndromes
Sofronas M.	-	Predictors of recurrent thrombo-embolic events in 153 infants and children with cerebral sinovenous thrombosis: a national population based study
Sogorb F.	-	Myocardial infarction in young patients: risk factors and thrombophilia study
	-	Hemostatic markers in nonrheumatic atrial fibrillation patients without anticoagulant therapy
Sohn H. Y.	-	Magnetofection – a highly efficient tool for endothelial gene transfer and antisense oligonucleotide delivery in vitro and in vivo
	-	A cytochrome P450 2C8/9-derived EDHF inhibits platelet adhesion to endothelial cells in vitro
Söhne M.	-	Effectiveness of excluding pulmonary embolism in the elderly by using a clinical decision rule and d-dimer
	-	Thrombophilia strikes at all ages
	-	Brain natriuretic peptide (BNP) as a predictor of adverse outcome in patients with pulmonary embolism
Sohne M.	-	The prevalence and prognostic importance of elevated cardiac troponins in patients with acute submassive pulmonary embolism
Söhne M.	-	d-dimer as a prognostic marker in patients with pulmonary embolism
Söhngen D.	-	Genetic profiling of 20 patients with FVII deficiency by dHPLC and sequence analysis: detection of 7 novel mutations
Sokolova O.	-	The molecular mechanisms of platelet activation by prolactin
Soldera C.	-	Type Vicenza Arg1205His mutation alone induces reduction in the level and survival of von Willebrand factor
Solenthaler M.	-	Splenectomy in relapsing and plasma-refractory thrombotic thrombocytopenic purpura
Sollier	-	Age influence on D-Dimer in a large normal French population: the FITENAT study
Solomon A.	-	FXIII promotes endothelial cell migration, proliferation, and inhibits apoptosis
Soloviev A. I.	-	Impairment of morphology and NO release in cultured endothelial cells from rabbit coronary vessels following total irradiation by external CO60
Solpov A.	-	Influence of monocyte on lymphocyte-platelet adhesion
Solum N. O.	-	Interleukin-7-mediated inflammation in unstable angina – possible role of chemokines and platelets
	-	Solubilization of CD40L (CD154) from platelets after activation and secretion: proteolysis directly on the platelet surface or after receptor-mediated internalization?
Solymoss S.	-	Activated protein C resistance in cancer-associated venous thromboembolism
	-	Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
	-	Resource utilization and loss of productivity during the 4 months following a diagnosis of deep venous thrombosis
Somerville R. A.	-	Removal of a BSE-derived agent by ion exchange chromatography used in the manufacture of a high purity factor VIII concentrate
Sommeijer D. W.	-	Effect of pravastatin on plasma markers of coagulation and inflammation in type 2 diabetes
	-	Rapid arterial thrombus formation after endothelial injury in streptozotocin-induced diabetic mice
	-	Symptomatic plaques of type 2 diabetic patients show more plaque complications but similar expression patterns of markers for coagulation and inflammation compared to nondiabetic controls
Sommer S.	-	Hemophilia as a model for analysis of human germ-line mutagenesis: frequent mosacism and low male to female sex ratio for G:C®A:T nonCpG transitions and the first observation of a nucleotide bi-mutation are consistent with effects in early embryogenesis
Son D.	-	The anti-platelet activity of J78 is mediated mainly by inhibition of arachidonic acid metabolism
Sonaglia F.	-	A clinical outcome-based prospective study on venous thromboembolism in cancer surgery: the @RISTOS project
Song K.	-	Detection of Ala601-Thr mutation in dysplasminogenemic patients with thrombosis in Korean population
Song J. W.	-	Detection of Ala601-Thr mutation in dysplasminogenemic patients with thrombosis in Korean population
Sonie S.	-	A systematic review of the accuracy of ultrasound in the diagnosis of asymptomatic deep venous thrombosis: preliminary results
Sorarù M.	-	A double-blind placebo-controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter
Sorell L. T.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Sorensen B. B.	-	Anti-apoptotic effect of coagulation factor VIIa
Sorensen B.	-	Sample management and quality control in roTEG thrombelastography
	-	Whole blood clot formation profiles in patients with Bernard Soulier's and Glanzmann's disease. Ex vivo intervention with platelets and recombinant factor VIIa
Sorensen K. W.	-	Inefficient secretion and intracellular degradation of factor V
Sorensen B.	-	Whole blood coagulation profiles in patients with thrombosis
	-	Real-time whole-blood coagulation following ex vivo hemodilution with plasma substitutes: reversal of the coagulopathy by a fibrinogen concentrate
Sorensen B.	-	Potential effect of recombinant factor VIIa in ex vivo reversal of pentasaccharide induced anticoagulation
Sorensen K. W.	-	H1299R mutation results in retention of mutant factor V molecule in the Golgi complex: a possible novel type of quantitative defect
Sorensen B.	-	Recombinant factor VIIa in management of acute CNS and GI bleedings during warfarin thromboprophylaxis: clinical and biochemical aspects
Sorensen J. C.	-	Recombinant factor VIIa in management of acute CNS and GI bleedings during warfarin thromboprophylaxis: clinical and biochemical aspects
Sorensen B.	-	Phenotypic variation in real-time whole blood clot formation profiles in severe hemophilia. Response patterns following ex vivo addition of rFVIII and rFIX
Sorensen B.	-	Whole blood coagulation response patterns to ex vivo added recombinant factor VIIa in Hemophilia A, Hemophilia B, and other inherited coagulation factor disorders
Soria J. M.	-	Genetic dissection of thrombin-activatable fibrinolysis inhibitor (TAFI)
	-	A genome-wide scan for genetic loci influencing levels of thrombin-activatable fibrinolysis inhibitor (TAFI)
	-	Transmission electron microscopy of granulocyte inclusions in genetically confirmed MYH9-related disorders
	-	The 46C®T polymorphism in F12 gene is a risk factor for coronary artery disease
	-	Factor VII plasma levels and the F7 structural gene: complete dissection of a human quantitative trait locus
	-	Functional resequencing of the factor IX (f-IX) gene: identifying quantitative trait nucleotides (QTNs) underlying the variation in plasma f-IX activity levels in the GAIT project
	-	The 46C®T polymorphism in the F12 gene is a risk factor for ischemic stroke
Soria C.	-	Human endothelial cells synthesize Protein Z
Soria J. M.	-	Functional re-sequencing of the factor VIII (f-VIII) gene: identifying quantitative trait nucleotides (QTNs) underlying the variation in plasma f-VIII activity levels in the Gait Project
	-	A quantitative trait locus on chromosome 11 is the major genetic determinant of homocysteine plasma levels. Results from the GAIT Project
	-	The 46C®T polymorphism in the F12 gene as a risk factor for venous thrombosis: association after linkage analysis
Soria J.	-	Inhibition of angiogenesis by statins: a possible contribution for the protection of the vascular risk in atherosclerotic patients
Soria C.	-	Inhibition of angiogenesis by statins: a possible contribution for the protection of the vascular risk in atherosclerotic patients
	-	The anti-angiogenic effect of endostatin is associated to a direct effect on the tumor growth in colon cancer
Soria J. M.	-	Complexity of the genetic contribution to Factor VII deficiency in two Spanish families: clinical and biological implications
Sortino G.	-	Desmopressin subcutaneous administration enhances platelet response ‘in vivo’ to Platelet-Activating Factor (PAF) and causes a rise in interleukin-6 plasma levels in haemophilia A and von Willebrand disease type I
	-	The platelet glycoprotein IIb/IIIa receptor antagonist c7E3Fab inhibits the coagualation activation in patients undergoing to percutaneous transluminal coronary angioplasty (PCTA)
	-	Sickle cell disease, vascular endothelium dysfunction, abnormal endothelin-1 release, interleukin-6 plasma level, hyperhomocysteinaemia and thromboembolic risk
Soskov G. I.	-	Cases of development of an idiopathic thrombocytopenic purpura at children associated with introduction of a tuberculin
	-	Using NovoSeven (NS) – recombinant factor VIIa to control the bleedings in Bernard-Soulier (BSS) girl. Case report
	-	The experience of treatment of children with hemostasis system pathology treatment with recombinant factor VII NovoSeven
	-	Results of clinical use of ‘NovoSeven’ in Russia
	-	Idiopathic thrombocytopenic purpura at children, associated with a virus of rubella
	-	The principles of therapy of hemorrhagic vasculitis at children
Sotirelos K.	-	Genetic risk factors in patients with myocardial infarction and correlation with echocardiographic study
Soto C.	-	TNF-alpha promoter polymorphisms (-238 and -308) in patients with cerebrovascular disease
Soubrier F.	-	Inherited thrombophilia is not associated with an increased risk of intrauterine fetal death
Soucie M. J.	-	Renal disease among persons with hemophilia
	-	Heart disease among males with hemophilia
Soulat T.	-	Prevention of wine consumption on thrombosis but not on atherosclerosis in ApoE-/- mice
	-	A comparative pharmacodynamic study of anti-Xa activity to evaluate the accumulation effect of Tinzaparin and Enoxaparin given at prophylactic dose over 8 days in elderly patients with impaired renal function
Soulet C.	-	Activation of RhoA and Rac through Gq- and G12/G13-mediated pathways in mouse and human platelets stimulated by TXA2 or ADP
Souri M.	-	Expression pattern and intracellular localization of the A subunit for coagulation factor XIII
Sousa M. A. J.	-	Ligneous conjunctivitis: report of two cases
Sousa Mendes D.	-	Treatment of acquired factor VIII inhibitor using Feiba and Prednisone
	-	rFVIIa (Novoseven®) in the treatment of Glanzmann's Thrombastenia
Southward S. M. R.	-	Fibrinolysis within the procoagulant VX-2 tumor of rabbit lungs in vivo: Anti-angiogenic behavior of fibrin(ogen) degradation products
Souto J. C.	-	Factor VII plasma levels and the F7 structural gene: complete dissection of a human quantitative trait locus
	-	Self-management of oral anti-coagulation reduces the incidence of complications: preliminary results of the ACOA clinical trial
	-	The 46C®T polymorphism in F12 gene is a risk factor for coronary artery disease
	-	A genome-wide scan for genetic loci influencing levels of thrombin-activatable fibrinolysis inhibitor (TAFI)
	-	Genetic dissection of thrombin-activatable fibrinolysis inhibitor (TAFI)
Souto J.	-	Heritability of plasma antiphospholipid antibodies
Souto J. C.	-	Transmission electron microscopy of granulocyte inclusions in genetically confirmed MYH9-related disorders
Souto J.	-	A quantitative trait locus on chromosome 11 is the major genetic determinant of homocysteine plasma levels. Results from the GAIT Project
Souto J. C.	-	Functional re-sequencing of the factor VIII (f-VIII) gene: identifying quantitative trait nucleotides (QTNs) underlying the variation in plasma f-VIII activity levels in the Gait Project
	-	Incidence of venous thrombosis in carriers of familial thrombophilia with a personal history of venous thrombosis
	-	The 46C®T polymorphism in the F12 gene as a risk factor for venous thrombosis: association after linkage analysis
Souto J.C.	-	Genetic coregulation of C4b-binding protein (C4BP) and free Protein S plasma levels: a link between complement and hemostasis
Souto J. C.	-	Complexity of the genetic contribution to Factor VII deficiency in two Spanish families: clinical and biological implications
	-	The 46C®T polymorphism in the F12 gene is a risk factor for ischemic stroke
	-	Functional resequencing of the factor IX (f-IX) gene: identifying quantitative trait nucleotides (QTNs) underlying the variation in plasma f-IX activity levels in the GAIT project
Souza R. C. C.	-	Hemostatic parameters in Brazilian asymptomatic carriers of Factor V Leiden, prothrombin (G20210A) and methylenetetrahydrofolate reductase (C677T) mutations
Spaargaren-Van Riel C. C.	-	Functional analysis of the prothrombin (PT) G20210A variation
	-	Identification of transcription factor binding sites for HNF1-alpha, FOXA2, HNF4-alpha, Sp1 and Sp3 in the human prothrombin gene enhancer
Spanaki A.-M.	-	Left adrenal hemorrhage with intravascular coagulation- case report
Spanbroek R.	-	Evidence for a functionally active protease-activated receptor-3 in human vascular smooth muscle cells
Spandorfer J.	-	Clinical outcomes with the use of unfractionated heparin or low-molecular-weight heparin as perioperative bridging therapy in patients on long-term oral anti-coagulants: Rationale, objectives, and design of a large, long-term study (REGIMEN)
Spangenberg P.	-	Activated platelets and platelet-derived microvesicles (PMV) transfer tissue factor (TF) to monocytes but not to neutrophils
Spannagel U.	-	Prolonged prophylaxis with the low molecular weight heparin certoparin reduces the rate of venous thromboembolism after orthopedic surgery
Spannagl M.	-	Harmonization of D-Dimer test results
Spannagl A.	-	Rapid and automated quantification of the kinetics of thrombin formation using the Thrombin Dynamics Test (TDT)
	-	Improved differentiation between factor V wild type and factor V Leiden patients using a new prothrombin-based activated protein C resistance assay
Spannagl M.	-	The German thrombophilia-registry – first results: Women specific risk factors and venous thrombosis
	-	Factor XIII Val34Leu polymorphism in pediatric thrombophilia evaluation: is there clinical relevance?
Speckman J.	-	Quality assessment of anti-coagulation dose management: comparative evaluation of measures of time-in therapeutic range
Spector T. D.	-	Genetics of fibrin clot structure and interactions with factor XIII: a twin study
Speijer D.	-	A proteomic approach to identify plasma lipoprotein-associated proteins with a potential role in atherothrombosis
Spek C. A.	-	Tissue factor itself is vital for the development of cell types with constitutive tissue factor expression but not for cell types without such expression
	-	Blood-borne tissue factor aggravates the outcome of endotoxemia
	-	Differential effects of tissue factor haploinsufficiency during LPS stimulation
	-	Coagulant phenotype determines the outcome of septic peritonitis
Speletas M.	-	Thrombophilia and pregnancy
Spena S.	-	Congenital afibrinogenemia, identification of four novel homozygous mutations in the fibrinogen gene cluster: three point mutations and a 15-kb deletion
Spence V. A.	-	Increased plasma isoprostanes and other markers of oxidative stress in chronic fatigue syndrome
	-	Increased neutrophil apoptosis in chronic fatigue syndrome
Spiezia L.	-	Pseudogene coamplification mimicking a 14-bp deletion mutation in exon 5 of plasminogen gene: a methodological study
	-	Plasma fibrinolytic capacity and 4G/5G polymorphism of PAI-1 gene in heart and kidney transplant recipients with or without steroid immunosuppression
Spijkers P. P. E. M.	-	LDL-receptor related protein (LRP) interacts with leukocyte integrin CD11b/CD18: a novel pathway in inflammatory regulation?
Spila A.	-	Soluble CD40 ligand (sCD40L) plasma levels in nonsmall cell lung cancer
Spina D.	-	Platelet depletion abolishes eosinophil recruitment to the lungs and tissue remodelling in an allergic asthma model in mice
Spitzer S.	-	Anti-fibrinogen IgG from a thrombophilic A alpha R16C (Fibrinogen Northspring) proband accelerates release of clot bound thrombin by enhancing fibrinolysis: a novel thrombogenic mechanism
Spooner D.	-	Increased platelet adhesion in metastatic cancer
Spotts G.	-	Pilot introduction study of a needleless transfer device (BAXJECT) for reconstitution of Factor VIII concentrates for infusion
Spotts G.	-	Clinical evaluation of an advanced category recombinant FVIII, anti-hemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM) in pediatric previously treated patients (PTPs)
	-	Economic modeling of full-length anti-hemophilic factor (recombinant), plasma/albumin-free method (rAHF-PFM), vs. B-domain deleted rFVIII (BDDrFVIII) in previously treated patients (PTPs) with hemophilia A
Sprangers M. A. G.	-	Relation between compliance and quality of treatment with vitamin K antagonists
	-	The optimal duration of treatment with vitamin K antagonists in patients with a first episode of venous thromboembolism: a decision analytic approach
	-	Patients' valuation of outcomes after venous thromboembolism
	-	The balance between the benefits and risks of treatment with vitamin K antagonists as perceived by patients
Spray J. R. K.	-	The human protein C gene promoter is regulated by androgenic but not oestrogenic factors
Spreafico M.	-	A study of 130 Italian patients on anti-coagulant treatment: how variant alleles of gene CYP2C9 influence requirement dose of warfarin during the induction period of treatment
Spreafico M.	-	Lack of association between the annexin V gene -1C®T polymorphism and acute myocardial infarction in 150 young Italian women
Springolo F.	-	Safety and efficacy of nadroparin for the treatment or prophylaxis of venous thromboembolism in pregnancy
Spyra M.	-	Limiting the parvovirus B19 load in manufacturing pools results in final containers of plasma derivatives nonreactive for parvovirus B19 genome
Spyropoulos A. C.	-	Clinical outcomes with the use of unfractionated heparin or low-molecular-weight heparin as perioperative bridging therapy in patients on long-term oral anti-coagulants: Rationale, objectives, and design of a large, long-term study (REGIMEN)
Spyropoulos A.	-	A risk assessment model for identifying medical patients who should receive thromboprophylaxis
	-	A multinational observational cohort study in hospitalized medical patients of practices in prevention of venous thromboembolism and clinical outcomes: findings of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
Spyropoulos A. C.	-	Health care costs and clinical outcomes in patients on chronic oral anti-coagulation undergoing perioperative bridging with low-molecular-weight heparin vs. unfractionated heparin
Squizzato A.	-	Determinants of delayed thrombus regression after deep vein thrombosis of the lower limbs: a prospective cohort study
	-	Early developments of the post-thrombotic syndrome in overweight and obese patients
	-	Weight changes after acute deep venous throbosis: a prospective observational study
Srivastava A.	-	Factor IX gene deletions are a frequent cause of hemophilia B in India
	-	Clinical presentation of type 1 von Willebrand disease (VWD) in obligatory carriers: final results from a collaborative, international, multicenter study
Srivastava A.	-	Administration of gentamicin does not increase factor levels in severe hemophilia-B due to premature termination codons
	-	Three novel missense mutations in the b-propeller domains of GPIIb (aIIb integrin) among three unrelated patients with Glanzmann thrombasthenia from southern India
Srivastava A.	-	Comparison of hemorrhagic symptoms in obligatory carriers of type 1 and type 3 von willebrand disease (VWD): results from a collaborative, international, multicenter study
Stabile A.	-	Impairment of fibrynolytic capacity in experimentally induced ketoacidosis in continuous subcutaneous insulin infusion patients
Stackelberg J.	-	Advoy – a communication tool for better care in haemophilia
Stafford N.	-	The mechanism of platelet aggregation in whole blood in response to adenosine triphosphate: involvement of neutrophil ecto-ATPase activity and adenosine
Stafford A. R.	-	gA/g' fibrin affords thrombin greater protection from inhibition by the heparin/antithrombin complex than gA/gA fibrin
Stafford A.	-	GH9001, a novel anti-thrombotic agent, is more effective than low-molecular-weight heparin, fondaparinux, or hirudin in rabbit models
Stafford D. W.	-	Improving efficacy of gene therapy of hemophilia B by the use of mutant FIX variants
Stagg S.	-	Inactivation of non-enveloped viruses by non-ionic detergent and solvent/detergent in the fibrinogen component of fibrin sealant
Stahle M. C.	-	Integrin clustering mechanisms explored with a soluble aIIbb3 ectodomain construct
Stain A. M.	-	Central venous catheter-related thrombosis presenting as SVC syndrome in a hemophiliac with inhibitors
	-	Central venous catheter (CVC) related thrombosis in boys with hemophilia
	-	Patterns of factor prophylaxis in the Canadian hemophilia A population
	-	Final results from the Canadian hemophilia dose escalation prophylaxis trial
Stain M.	-	The effect of b-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolism
Stakkestad A.	-	Elevated concentrations of nitrate in plasma from smokers
	-	Prevalence of hyperhomocysteinemia among aluminum industry workers
Stalc J.	-	Comparison of magnetic resonance characteristics of the vessel wall between patients with classic and dilatative atherosclerosis
Stalc M.	-	Safety of the transfer of patients on anticoagulant therapy from hospital anticoagulant clinics to general practitioners using a computer-decision support
Stallard L.	-	Hypercoagulability in inflammatory bowel disease
Stallone C.	-	Occurrence of myocardial infarction and PAI-1 4G/5G and ACE I/D gene polymorphisms in patients on chronic dialysis
Stalmeier P. F. M.	-	The balance between the benefits and risks of treatment with vitamin K antagonists as perceived by patients
	-	The optimal duration of treatment with vitamin K antagonists in patients with a first episode of venous thromboembolism: a decision analytic approach
	-	Patients' valuation of outcomes after venous thromboembolism
Stamm M.	-	Cross–species interactions of FXIII and fibrinogen
Stanczyk L.	-	Is plasma homocysteine concentration different in diabetic and nondiabetic stroke patient up to the age of 55?
Standeven K. F.	-	Fibrinogen gamma chain splice variant (g') alters fibrin structure and function
Stangier J.	-	The effect of BIBR 953 ZW, the active form of the oral direct thrombin inhibitor BIBR 1048, on the prolongation of aPTT and ECT in orthopedic patients: a population pharmacodynamic study
	-	Pharmacokinetics of BIBR 953 ZW, the active form of the oral direct thrombin inhibitor BIBR 1048, in patients undergoing hip replacement
Stankiewicz L.	-	Antithrombotic action of perindopril in experimental venous thrombosis in young rats
Stankovic S.	-	Acquired postpartum hemophilia: report of a case
Stanson A. W.	-	Combined mechanical and pharmacologic thrombolysis for ilio-femoral deep venous thrombosis. Single center short-term outcomes
Starke R.	-	Expression of prion protein (PrPC) in the megakaryocyte lineage
Staroverov I.	-	The influence of treatment with low molecular weight heparins (dalteparin, nadroparin) on the clinical course and hemostasis activation markers in patients with unstable angina
Stasiak M.	-	The role of integrin alpha2beta1 during activation of protein tyrosine kinases induced by low concentration of collagen
Stasko J.	-	Epidemiology of inherited thrombophilia in Slovakia
	-	TAFI and diabetic nephropathy
Staton J. M.	-	Prediction and prevention of thrombosis during pregnancy and oestrogen use
Staudinger T.	-	Treatment of adults with sepsis-induced coagulopathy and purpura fulminans with a plasma-derived protein C concentrate (Ceprotin®)
Stauropoulos G. P.	-	Synthetic tripeptides with specific inhibitory action against Gp-Ib glycoprotein
Stearns-Kurosawa D. J.	-	Soluble endothelial cell markers (sTM, sEPCR and sVWF) in type 2 diabetes
Steegers E. A. P.	-	Preconceptional, gestational and puerperal low anti-annexin A5 antibody levels in women who develop pre-eclampsia
Steegers-Theunissen R. P. M.	-	Preconceptional, gestational and puerperal low anti-annexin A5 antibody levels in women who develop pre-eclampsia
Steegh N.	-	Incidence of thrombosis in gastro-esophageal cancer: a cohort study of 649 patients
Steele P. J.	-	Removal of a BSE-derived agent by ion exchange chromatography used in the manufacture of a high purity factor VIII concentrate
Steen M.	-	Severe thrombophilia in two brothers due to novel combination of mutations in factor V gene producing quantitative deficiency (Glu119Term) and decreased sensitivity to activated protein C due to a novel glycosylation site (Ile359Thr-FV Liverpool)
Steen L. H.	-	Platelet and inflammatory changes induced by angioplasty and brachytherapy
Steen M.	-	Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized
Steen M.	-	Effects of Factor Xa and protein S on the individual APC-cleavage sites of factor Va
Steen M.	-	Functional characterization of recombinant Factor V Liverpool: Ile350Thr, a novel mutation associated with thrombosis
Stefani P. M.	-	The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study
Stefano P. L.	-	Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
	-	Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
Stefano P.L.	-	Assessment of platelet function during cardiopulmonary bypass using two new "point of care" devices
Stefenelli T.	-	High dose of atorvastatin does not effect levels of plasma tissue factor in patients with coronary artery disease
Stegnar M.	-	The frequencies of fibrinogen polymorphisms Taq I, Hae III and Bcl I in patients with deep-vein thrombosis
Stehle T.	-	Structure of the alphaVbeta 3 receptor
Steidl L.	-	Weight changes after acute deep venous throbosis: a prospective observational study
	-	Early developments of the post-thrombotic syndrome in overweight and obese patients
	-	Determinants of delayed thrombus regression after deep vein thrombosis of the lower limbs: a prospective cohort study
Stein P. D.	-	Tracking the uptake of evidence: two decades of hospital practice trends for diagnosing deep vein thrombosis and pulmonary embolism
	-	D-dimer for the exclusion of acute deep venous thrombosis and pulmonary embolism: a systematic review
Stein S. F.	-	Treatment and management of women with bleeding disorders and menorrhagia (WBDM) study: study design and characteristics of women enrolled
Steiner B.	-	Discrepancies in potency assessment of B-domain deleted recombinant factor VIII among different one-stage factor VIII clotting assays
Steiner B.	-	Blockade of GPIIb/IIIa by abciximab, eptifibatide and tirofiban at high shear results in a differential inhibition of platelet aggregation, platelet microparticle formation and phosphatidylserine exposure
Steiner S.	-	High dose of atorvastatin does not effect levels of plasma tissue factor in patients with coronary artery disease
Steiner B.	-	Thrombin binding to GPIba induces platelet adhesion, aggregation and fibrin clot retraction supported by resting a Iibb 3 interaction with polymerized fibrin
Steiner S.	-	Abciximab reduces monocyte tissue factor after carotid angioplasty and stenting: role of monocyte platelet cross talk in cerebral microembolization
	-	Abciximab reduces monocyte tissue factor after carotid angioplasty and stenting: role of monocyte platelet cross talk in cerebral microembolization
Steinmetz C.	-	Reliability of patient self-testing and point-of-care testing with the Harmony (TM) INR monitoring system: a 3-year study
Steins M.	-	Overexpression of basic fibroblast growth factor (bFGF) in the bone marrow of patients with acute myeloid leukemia: a potential role for bFGF as an autocrine growth factor
Stemberger A.	-	Fibrinogen – a new tool for gene delivery
	-	Contrast media and compounds containing iodine prevent fibrin formation
Stemberger M.	-	Contrast media and compounds containing iodine prevent fibrin formation
	-	Contrast media and compounds containing iodine prevent fibrin formation
Stemmelin G.	-	Safety considerations of Enoxaparin as an alternative to oral anti-coagulants in high risk cardioembolic patients with a programed surgical procedure. SWITCH trial
	-	High levels of factors VIII, IX and XI in patients with a thromboembolic event
Sten-Linder M.	-	The t-PA/PAI-1 complex in plasma in relation to risk of myocardial infarction as evaluated in the Stockholm heart epidemiological program (SHEEP)
Sten-Linder M.	-	Prospective evaluation of t-PA/PAI-1 complex predicting myocardial infarction in controls included in the SHEEP study
Stepanian A.	-	Mutation of cysteines 1157 or 1234 located within the D3 domain of Von Willebrand Factor causes intracellular retention of high molecular weight multimers
Stepanov R. P.	-	Unusual persistent cell damages in irradiated rat endothelium as a model in study pathophysiology of atherosclerosis and thrombosis
Stephan B.	-	On the role of platelets, and homocysteine in thrombotic patients, healthy controls and mutant carriers of methylentetrahydrofolate reductase (‘MTHFR’) (C677T)
	-	Thrombophilia – from the roots to the base of evidence. Preliminary results on platelet function and rheologic parameters and the necessity of prospective multicentre cohort trials
	-	Evidence of C677T methylentetrahydrofolate reductase (‘MTHFR’) and hyperhomocysteinemia (HH) – causal or casual coexisting risk factors?
Stephens G.	-	Platelet activation causes a metalloprotease-mediated down-regulation of GlycoproteinVI
Stephensen D.	-	Advoy – a useful clinical tool in the management of the patient with hemophilia on home therapy
Stepien O.	-	Evidence for extracellular signal-regulated kinase 1/2 activation by thrombin that is independent on epidermal growth factor receptor transactivation in vascular smooth muscle cells
Steppich B.	-	Proteolysis of tissue factor pathway inhibitor-1 on circulating microparticles after thrombolysis in acute myocardial infarction contributes to thrombin formation
Sterba J.	-	rFVIIa NovoSeven®– Hemostatic agent not only for hemophiliacs
	-	Multi-diagnostic retrospective study of risk factors of thrombosis in children with cancer – is there a space for multivariate predictive modeling?
Stern D. M.	-	Long-term RAGE-mediated NF-kB activation in diabetic neuropathy and its role in loss of pain perception
	-	The natural anticoagulant Thrombomodulin has radical scavenging activity and acts as an antioxidant C-type lectin
Steuer S.	-	Platelet receptor polymorphism HPA-1b and the G20210A mutation of the prothrombin-gene are risk determinants of vascular access thrombosis in hemodialysis patients
Steurer S.	-	Urokinase receptor (uPAR) regulates integrin redistribution during initial vascular endothelial growth factor (VEGF)-induced endothelial cell migration
Stevens J. M.	-	The inhibitory action of quercetin on GPVI-mediated platelet signaling and activation
	-	A role for the thiol isomerase protein P5 in platelet function
Stevenson K. J.	-	Improving the quality of INR determination in the anticoagulation clinic
Steward S. A.	-	aIIbb3 activation by botrocetin/vWf is ADP or TXA2 dependent and the resulting aIIbb3 outside-in signaling is the major trigger for subsequent granule release and TXA2 production
Stewart R.	-	Postpartum levels of activated TAFI (TAFIa) in patient plasmas
Stewart D.	-	Distinct dose-dependent effects of plasmin and TPA on coagulation and haemorrhage
Sticchi E.	-	TAFI plasma levels are not increased in ischemic heart disease patients admitted to a coronary care unit
	-	New risk factors for coronary artery disease: the endothelial nitric oxide synthase polymorphisms
	-	Angiotensin converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation
Stieltjes N.	-	A retrospective evaluation of the use of B-domain deleted recombinant Factor VIII (ReFacto®) administered by continuous infusion during surgical procedures
	-	Efficacy and safety of the first nanofiltered plasma-derived FVIII (FACTANE®) in previously treated haemophilia A patients
Stier-Brück I.	-	Malignancy and metastasis is not associated with decreased ADAMTS-13 activity in patients with brain tumors and prostate tumors
Stigendal L.	-	Hand computer and Internet for collection and presentation of patient diary data in a Nordic clinical multicenter safety surveillance study of ReFacto®
Stigl B.	-	Safety of the transfer of patients on anticoagulant therapy from hospital anticoagulant clinics to general practitioners using a computer-decision support
Stihle M.	-	The active conformations of Factor VIIa and Factor IXa: biochemical, biophysical, chemical and crystallographic studies
Stijnen P. J.	-	The assessment of pretest probability in patients with suspected Deep-Vein Thrombosis is of great value in nonacademic teaching hospitals
Stiller P.	-	Extrinsic pathway function, thrombin generation potential and perioperative blood loss in CABG surgery
Stocker C.	-	Factor V Leiden mutation (FV:Q506): A new functional screening assay with 100% specificity and sensitivity
Stojanovic A. S.	-	Acquired postpartum hemophilia: report of a case
Stoldt V.	-	Influence of anti-thrombin on platelet adhesion onto immobilized fibrinogen in simulated low flow in vitro system
Stoll H.	-	Clinical manifestation and therapy in children with hereditary angioedema (HAE) – a prospective follow up
	-	Successful immune tolerance therapy in hemophilia B patients with fix: a new immunesuppressive strategy
	-	Long-term prophylaxis with FEIBA® in patients with high-responding inhibitors
Stone P. C. W.	-	Neutrophils rapidly recruited by TNF-a stimulated endothelial cells can exit the sub endothelial environment by reverse transmigration over hours: is this a novel route for neutrophil clearance from inflamed tissue?
Stone W.	-	A quantitative trait locus on chromosome 11 is the major genetic determinant of homocysteine plasma levels. Results from the GAIT Project
Stone P. C. W.	-	Neutrophils recruited by TNF-a stimulated endothelial cells down regulate subsequent endothelial VCAM-1 expression and inhibit the adhesion of a secondary bolus of flowing peripheral blood lymphocytes
Stonebraker J. S.	-	Probabilistic modeling of population-based epidemiology and treatment modalities to determine unconstrained factor VIII demand
Stonelake P.	-	Increased platelet adhesion in metastatic cancer
Stoppini A.	-	Oral anticoagulation telemedicine management system: the MC-SAT project
Storelli C.	-	Statins inhibit cyclo-oxygenase (cox)-2 and metalloproteinase (mmp)-9 expression in human endothelial cells: possible contribution to plaque stability
Storey R. F.	-	Effects of ADP-antagonists on platelet calcium mobilization in acute coronary syndrome patients
Straatsburg I. H.	-	Factor VIII expression in liver disease
Strabach S.	-	Variations of INR and Factor VII Level are linked to Cytochrome P450 2C9 genotype
Stradling J. R.	-	Increased circulating cardiovascular risk factors in obstructive sleep apnoea and the effect of CPAP therapy
Straeter R.	-	Sinus venous thrombosis in children – a multifactorial etiology
Strandberg K.	-	Evaluation of an automated assay for rapid analysis of von Willebrand ristocetin cofactor activity
Stratigakis G.	-	Levels of plasma tissue activator plasminogen (tPA)- A useful marker in the differential diagnosis of chest pain (marker of plaque destabilization)
Stratz C.	-	Proteolysis of tissue factor pathway inhibitor-1 on circulating microparticles after thrombolysis in acute myocardial infarction contributes to thrombin formation
Street A.	-	Laboratory diagnosis of von Willebrand Disorder: current and past practice in Australasia
Street A. M.	-	Low detection rate of antibodies to nonfunctional epitopes on factor VIII in patients with hemophilia A and negative for inhibitors by Bethesda assay
Streja E.	-	The G>T point mutation in codon 34 of the factor XIII gene and the risk of pre-eclampsia
Strey A.	-	Thrombospondin-1 promotes transendothelial migration of monocytes associated with platelets
Stricker H.	-	Influence of acute cigarette exposition and of a 2-week substitution with folic acid on parameters of blood coagulation, fibrinolysis and homocysteine in healthy smokers
Strickland D.	-	Diverse roles of LRP in clearance of proteases and in signaling
Strickland S.	-	tPA as a modulator of neuronal function and survival
Strobel U.	-	Cross-reactivity of anti-lepirudin antibodies from patients with heparin-induced thrombocytopenia with bivalirudin
STROKE STUDY GROUP CANADA	-	Predictors of recurrent thrombo-embolic events in 153 infants and children with cerebral sinovenous thrombosis: a national population based study
Strong J.	-	Evaluation of the role of genetic analysis in dysfibrinogenemia
Stroop D.	-	Legg-Perthe's disease and thrombophilia: a causal association?
Strukelj M.	-	Shear rate of plasma flow and fibrin specificity of thrombolytic agent promote thrombolysis of nonretracted and retracted whole blood clots – a MRI study in vitro
Strukova S.	-	Thrombin-mediated Ca2+ responses in chick embryo cardiomyocytes and cardiofibroblasts
Strukova S. M.	-	Thrombin accelerates regeneration of mouse peripheral nerve in vivo
Strunz C. M. C.	-	Analysis of the effectiveness of the D-Dimer test to exclude acute venous thromboembolism
	-	Comparison of the point-of-care method for oral anti-coagulation control with the conventional method
Struve S.	-	Successful treatment with rituximab in a case of relapsed acquired hemophilia
Stuart M. J.	-	Tissue factor in sickle cell disease: Source and potential mediators
	-	A novel endothelial receptor involved in red cell-endothelial cell adhesion
Stüdemann C.	-	A novel recombinant factor VIII produced by a human cell line functionally restores coagulation deficits in a mouse model of hemophilia A
Studt J. D.	-	Splenectomy in relapsing and plasma-refractory thrombotic thrombocytopenic purpura
Studt J. D.	-	Multicenter comparison of assays for von Willebrand factor-cleaving protease (ADAMTS13) activity
Studt J.-D.	-	Analysis of ADAMTS13 activity in consecutive patients with clinically diagnosed thrombotic thrombocytopenic purpura – hemolytic uremic syndrome (TTP-HUS)
Studt J. D.	-	Observations on immunoadsorption (IA) as an auxiliary therapy for acquired thrombotic thrombocytopenic purpura (TTP)
Studt J. D.	-	ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS-13
Sturgeon S.	-	Phosphoinositide 3-kinase beta (PI3Kb): a novel target for antithrombotic therapy
Sturk A.	-	Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner
	-	Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo
	-	Endothelial cell and monocyte-derived microparticles in severe dengue virus infections
	-	Recombinant truncated tissue factor triggers coagulation in normal human plasma via the extrinsic pathway
	-	Subpopulations of tissue factor-exposing microparticles from platelets and T-cells colocalize leukocytic antigens in uncomplicated human type 2 diabetes
	-	Age and first INR after standard initiation of oral anti-coagulant therapy with acenocoumarol predict the maintenance dosage
	-	Soluble tissue factor released by cultured human umbilical vein endothelial cells is microparticle-associated and triggers thrombus formation in vivo
	-	Phospholipid composition of cell-derived microparticles determined by one-dimensional high-performance thin layer chromatography
Sturk-Maquelin K. N.	-	Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner
Sturm D.	-	Reproducibility of anticoagulation therapy control tested on fresh and frozen plasma
Sturn D. H.	-	Eosinophils as a novel target for protein C
Sturn D. H.	-	Expression of endothelial protein C receptor by human neutrophils and its role in cell migration
Stürzebecher J.	-	A rapid chromogenic method for determination of TAFI in plasma samples
Stutz M.	-	Nonmechanical intraoperative bleeding diathesis shows properties of a consumptive disorder allowing preoperative risk stratification
Su Y. T.	-	Enhanced anti-angiogenesis ability of human kringle 1–5 domain via altering glycosylation sites and lysine binding properties
Su J.	-	Observation of preventive and therapeutic effects of anti-thrombin-III on experimental disseminated intravascular coagulation
Su K.	-	Consequences of expression of hepsin in murine vascular systems
Su Z.	-	Sensitivity and specificity of the abnormal optical waveform profile in the prothrombin time from patients with antiphospholipid antibodies
Suarez C.	-	Management and outcome of patients with venous thromboembolism: a prospective registry including over 5000 consecutive patients
Subel B.	-	Combined modality inhibitor eradication in a patient with mild hemophilia A and comparison of methods of inhibitor monitoring
Subirá D.	-	TNF-alpha promoter polymorphisms (-238 and -308) in patients with cerebrovascular disease
Suchkova V. N.	-	Low intensity ultrasound increases endothelial cell nitric oxide synthase activity
Suchkova V.	-	Ultrasound improves myocardial perfusion in a canine model of myocardial infarction
Suda T.	-	Activated protein C induces angiogenesis in vivo and in vitro
Sueishi K.	-	Involvement of VEGF-C/flt-4 system in therapeutic angiogenesis of FGF-2 gene transfer in murine ischemic hind limb
	-	Immunohistochemical expression of interleukin-10 (IL-10) in atherosclerotic intimas of human coronary arteries
	-	Platelet-derived growth factor receptor-alpha signaling is required for therapeutic angiogenesis induced by fibroblast growth factor-2
Sueishi K. S.	-	Recombinant sendai virus-mediated intramuscular gene transfer of FGF-2 restores collateral blood perfusion of chronically ischemic rabbit hind limb, and inhibits neointimal hyperplasia of autologous femoral vein grafts
Sugano T.	-	ADP regulates the expressions of tissue-type plasminogen activator (tPA) and plasminogen activator inhibitor-1(PAI-1) in rat aortic endothelial cells
Sugidachi A.	-	Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747, a novel P2Y12 receptor antagonist
	-	Effects of CS-747, a novel P2Y12 receptor antagonist, on cerebral and peripheral arterial occlusive diseases in rats
Sugidachi A.	-	Anti-platelet and anti-thrombotic effects of CS-747, a novel P2Y12 receptor antagonist, in combination with aspirin
Sugimoto M.	-	Mural thrombus generation in classic hemophilia under whole blood flow conditions
	-	Blood coagulation during mural throbogenesis under whole blood flow conditions with high shear rates
Sugiura-Ogasawara M.	-	Coagulation factor XII activity, but not an associated common genetic polymorphism, is linked to recurrent miscarriage
Sugiyama N.	-	The effect of direct FXa inhibitor and direct thrombin inhibitor on TF induced DIC and venous thrombosis models in anesthetized rat – thrombin inhibitor enhance the platelet consumption in DIC model
	-	DX-9065a, a direct factor Xa inhibitor prevents both arterial and venous thrombosis in rats via blocking prothrombinase complex activity – comparison with fondaparinux, an antithrombin dependent factor Xa inhibitor
Sugiyama K.	-	Prediction of the organ dysfunctions by coagulation/fibrinolysis molecular markers at the beginning of sepsis
Sugo T.	-	Neonatal injection of human factor VIII induces immune tolerance in murine hemophilia A
Suhoverhova A.	-	Efficacy of 1-year acenocumarol therapy and its relation with gene polymorphism related to thrombophilia in patients with nonvalvular atrial fibrillation
Suiter T. M.	-	Determination of High-Molecular-Weight von Willebrand factor multimers and their impact on specific VWF-activities in VWF/FVIII-concentrates
Suiter T.	-	Comparison of von Willebrand factor activities measured by ristocetin cofactor assay and two different VWF-collagen-binding-assays in VWF/FVIII-concentrates
Sukesh C. N.	-	Geographic distribution of asymptomatic constitutional macro thrombocytopenia in Indian subcontinent
Sukhu K.	-	The PFA-100®: a screening tool for platelet dysfunction – the Oxford experience
Sukhu K.	-	‘Aspirin resistance’ detected by high shear platelet function testing within the pilot phase of the Oxford Vascular Study (OXVASC)
Sullenger B. A.	-	Effect of a RNA-thrombin aptamer on thrombin inhibition by antithrombin, heparin cofactor II and protein C inhibitor
Sumarokov A. B.	-	Platelet activity and circulating leukocyte-platelet aggregates can be markers of thrombotic and inflammatory processes in patients with coronary atherosclerosis
Sumi H.	-	Natto Bacillus (Bacillus subtilis natto) as an oral fibrinolytic agent
	-	Isolation and administration effect of fibrinolysis accelerating substance (FAS) in the fermented soybean food, natto
Sumiya M.	-	Characterization of anti-factor VIII antibodies using Time-Resolved Fluoroimmunoassay
Sumiyoshi S.	-	Immunohistochemical expression of interleukin-10 (IL-10) in atherosclerotic intimas of human coronary arteries
Sumiyoshi A.	-	Coagulation system and inflammation significantly contribute to thrombus formation in ruptured plaques than erosive plaques of acute myocardial infarction
Sumoy L.	-	Human vitamin K-dependent Gas6 gene: exon–intron structure and identification of allelic variants
Sun Y.	-	The influence of the substitution of arginine within the RGD tripeptide motif of dendroaspin on its activity as a potent inhibitor of platelet aggregation and cell adhesion
Sun Z.	-	Increased fibronectin secretion but not cell surface expression in thrombin-activated platelets of hypofibrinogenemia patients
Sun H.	-	The factor V Leiden mutation results in the in vivo loss of a critical FV anticoagulant function
Sun Y.	-	Gla-domain mutated human protein C demonstrating enhanced inactivation of both factor Va and factor VIIIa
Sun L.	-	Association of impaired agonist stimulated platelet GPIIb–IIIa activation and pleckstrin phosphorylation with transcription factor CBFA2 mutation: proteins regulated by CBFA2 play a role in GPIIb-IIIa activation
	-	Economic modeling of full-length anti-hemophilic factor (recombinant), plasma/albumin-free method (rAHF-PFM), vs. B-domain deleted rFVIII (BDDrFVIII) in previously treated patients (PTPs) with hemophilia A
Sundar K. M.	-	Inflammatory modulation of alveolar coagulation inhibition in a mouse model of acute respiratory distress syndrome (ARDS)
Sundaresan P.	-	Functional significance of single-nucleotide polymorphisms in the glycoprotein VI gene
Sunder-Plassmann R.	-	A microsatellite polymorphism in the Heme Oxygenase – 1 gene promoter is associated with increased serum bilirubin and HDl levels but not with a decreased risk for coronary artery disease
	-	Platelet glycoprotein mRNAs are expressed in megakaryocytes and platelet like cells and are regulated during differentiation
Sundram F. X.	-	Radioisotopic synovectomy and haemophilic arthropathy in Asians: a retrospective study
Sundrani R.	-	Platelet and inflammatory changes induced by angioplasty and brachytherapy
Surdhar S.	-	Mutation analysis in type 1 von Willebrand disease patients entered in the multicenter MCMDM-1VWD study
Surdhar G. K.	-	Identification of six novel mutations in families with type 3 von Willebrand disease
	-	Inherited and de novo von Willebrand disease ‘Vicenza’ in UK families with the R1205H mutation
	-	Two candidate type 2 M von Willebrand disease mutations in two unrelated families with unusual phenotypes
	-	A common mutation 4247T ® A (I1416N) causing type 2M von Willebrand disease in patients from three unrelated families previously diagnosed as severe type 1 VWD
Surdhar G.	-	Compound heterozygous Protein C deficiency resulting in neonatal purpura fulminans: identification of a novel mutation and its functional consequences
Surdhar G. K.	-	Evaluation of a protein truncation test (PTT) for mutation detection in von Willebrand disease
Surrenti C.	-	Homocysteine plasma levels in primary biliary cirrhosis (PBC)
Susen S.	-	Effect of in vivo thrombin inhibition on bFGF-induced angiogenesis in a murine angiogenic model
	-	Tissue factor pathway in carotid atherosclerotic plaques: relationships with clinical patterns and risk factors
Susen S.	-	Tissue factor predicts long-term outcome after percutaneous coronary revascularization
Sutherland J.	-	An in silico analysis of type 2 A von Willebrand disease mutations
Sutherland J. S.	-	Alterations to the Leu444 (P1) residue of heparin cofactor II: Similarities and dissimilarities to HCII (L444R)
Sutherland D. R.	-	Platelet CD109: evidence for a transmembrane homologue on monocytes?
Sutherland J.	-	An ancient von Willebrand Disease (VWD) mutation that associates with a common haplotype in ~14% of type 1 VWD patients
	-	A type 2A (Group II) von Willebrand disease mutation (Leu1503Glu) associated with a minimal loss of high molecular weight von Willebrand factor (VWF) multimers
Sutor A. H.	-	Insufficient F IX-recovery after treatment with recombinant F IX compared to plasma-derived F IX
Suttiprapa S.	-	Detection of the factor XIIIA Val34Leu polymorphism in Thais
Suttnar J.	-	Influence of oxidatively modified low-density lipoproteins on platelet function
Suttnar J.	-	Resveratrol and trolox scavenge hydroxyl radicals produced in platelets activated by collagen
	-	Resveratrol and trolox scavenge hydroxyl radicals produced in platelets activated by collagen
Sutton J.	-	Elevated coagulation factors in rabbits (Oryctolagus cunniculus) following brown recluse envenomation (Loxoceles reclusa)
Suttorp M.	-	Correlation of parameters characterizing healthy newborns with cord blood concentration of thrombin activatable fibrinolysis inhibitor (TAFI)
Suzuki T.	-	Roles of the individual g-carboxyglutamic acid residues of factor VII
Suzuki N.	-	Anti-platelet and anti-thrombotic effects of CS-747, a novel P2Y12 receptor antagonist, in combination with aspirin
Suzuki S.	-	Anti-thrombotic effects of ER112787, a novel, nonpeptide thrombin receptor (PAR-1) antagonist, in a photochemically induced thrombosis model using guinea pigs
Suzuki K.	-	Plasminogen activator inhibitor-1 promotes fibrosarcoma cell migration by modifying cellular attachment to vitronectin via a vb 5 integrin
Suzuki H.	-	Factor V C2 domain contains major binding site for thrombin
Suzuki K.	-	EF6265: a new synthetic, potent and selective plasma CPB/TAFIa inhibitor
Suzuki Y.	-	Increased expression of endogenous tissue-type plasminogen activator and matrix metalloproteinase 9 contribute to heparin-produced cerebral hemorrhage after focal cerebral ischemia in mice
Suzuki K.	-	Decreased expression of protein C inhibitor in renal cell carcinoma cells is partly caused by DNA methylation
	-	C-reactive protein induces the expression of tissue factor and interleukin-8 in the lung
Suzuki J.	-	Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the Rho family
Suzuki K.	-	Activation of a novel 33-kDa SER/THR kinase by tyrosine kinase and calpain in thrombin-stimulated platelets
Suzuki S.	-	Successful argatroban-anticoagulant management for left ventricular assist system implantation in two patients with heparin-induced thrombocytopenia type II
Suzuki-Inoue K.	-	Integrin a2b1 stimulates platelet spreading through protein tyrosine phosphorylation and calcium mobilization
	-	Mechanisms of platelet retention in the collagen-coated bead columns
Suzuki-Inoue K.	-	PLCg2-independent activation of integrins by GPVI: involvement of PLCg1 and PI3-kinase
	-	GPVI- and GPIb/V/IX-induce tyrosine phosphorylation at Syk and PLCg2 at distinct sites
Suzumori K.	-	Coagulation factor XII activity, but not an associated common genetic polymorphism, is linked to recurrent miscarriage
Svaerd R.	-	Pharmacokinetics of BIBR 953 ZW, the active form of the oral direct thrombin inhibitor BIBR 1048, in patients undergoing hip replacement
Svane B.	-	A comparison of spiral computed tomography and latex agglutination D-dimer assay in acute pulmonary embolism using pulmonary arteriography as Gold Standard
	-	Spiral computed tomography has a higher sensitivity and specificity than d-dimer in the diagnosis of acute pulmonary embolism
Svensson B.	-	Interactions between tissue factor pathway inhibitor (TFPI) and lipoprotein lipase (LPL) in metabolism of very low density lipoproteins (VLDL)
Svensson J.	-	Effects of three low doses of aspirin on thromboxane synthesis in platelets and on bleeding time – a comparative study
Svensson P.	-	Incidence of venous thrombosis in carriers of familial thrombophilia with a personal history of venous thrombosis
Sverker J.	-	Platelets synthesize large amounts of PAI-1
Svirin P. V.	-	Results of clinical use of ‘NovoSeven’ in Russia
	-	The experience of treatment of children with hemostasis system pathology treatment with recombinant factor VII NovoSeven
	-	Plasma glycocalicin level in diagnosis of the idiopathic thrombocytopenic purpura (ITP) in children
Swadzba J.	-	Cerivastatin neither inhibits thrombin generation nor decreases markers of inflamation in patients with APS
Swan S. K.	-	Safety and tolerability of argatroban anticoagulation in patients with end-stage renal disease undergoing hemodialysis: a prospective study
Swan H.	-	Issues in monitoring direct thrombin inhibitors: comparison of a new, rapid Ecarin Clotting Time (ECT) test to activated clotting time (ACT) and anti-IIa assays
Swarup S.	-	cDNA sequence of the nonenzymatic subunit of pseutarin C, a prothrombin activator from the eastern brown snake (Pseudonaja textilis): its structural similarity to blood coagulation factor V
	-	The catalytic subunit of pseutarin C, a group C prothrombin activator from Pseudonaja textilis is structurally similar to blood coagulation factor X
Swedenborg J.	-	Influence of intraluminal thrombus on cellular and structural features of the aneurysm wall
Sweetman R.	-	Coexistence of multiple hemostatic genetic risk factors does not increase risk of coronary heart disease: The ARIC Study results
Swerlick R.	-	Inhibitors of NFkB and p38 kinase abrogate tissue factor up-regulation by anti-phospholipid antibodies
	-	Effects of fluvastatin on up-regulation of tissue factor by antiphospholipid antibodies
Swhorak N.	-	Anticoagulant heparan sulfate proteoglycans in mammalian reproductive function
Swiatkowska M.	-	Down-regulation of PAI-1 expression by natriuretic peptides is mediated by MAPK cascade in human endothelial cells
	-	Up-regulation of plasminogen activator inhibitor-1 (PAI-1) by thymosinb 4 in endothelial cells
Swiatkowska-Stodulska R.	-	Estimation of plasminogen activator inhibitor type 1 (PAI-1) and plasmin-alpha-2-antiplasmin complex (PAP) serum activities in personal computers operators
Swords Jenny N.	-	Intracellular adhesion molecule-1 is associated with cardiovascular disease in elderly men and women
Sydor W. J.	-	Factor V Leiden and blood coagulation at the site of microvascular injury in coumadin treated patients and healthy control
Sydor W. J.	-	Prognostic value of selected genetic variants of platelet glycoprotein receptors in prediction of thrombotic events after percutaneous coronary interventions
Sydor W. J.	-	Factor VIII activity and blood coagulation in patients on long-term oral anticoagulation
	-	Anti-phospholipid antibodies and carotid-artery intima-media thickness in young survivors of myocardial infarction
Sydor W.	-	Cerivastatin neither inhibits thrombin generation nor decreases markers of inflamation in patients with APS
Sydor W. J.	-	Novel polymorphic short tandem repeat in the human a2 integrin gene promoter is associated with GPIa/IIa density on the platelet surface
Syed K.	-	Elevated factor VIII: a possible link between periodontal disease and acute coronary syndrome
Syrbe G.	-	The development of inhibitors directed against factor VIII after continuous infusion of factor VIII concentrates in patients with hemophilia A
Szczeklik A.	-	Novel polymorphic short tandem repeat in the human a2 integrin gene promoter is associated with GPIa/IIa density on the platelet surface
	-	Cerivastatin neither inhibits thrombin generation nor decreases markers of inflamation in patients with APS
	-	Immediate anti-coagulant and anti-inflammatory effects of simvastatin and fenofibrate in patients with coronary artery disease
Szczeklik W.	-	Anti-phospholipid antibodies and carotid-artery intima-media thickness in young survivors of myocardial infarction
Szczeklik A.	-	Thrombin generation in response to methionine loading test in patients with ischemic heart disease
Szegedi N.	-	Thrombolytic therapy in acute ischemic stroke: same method, same team, different drug
Szemraj J.	-	Up-regulation of plasminogen activator inhibitor-1 (PAI-1) by thymosinb 4 in endothelial cells
Szemraj J.	-	Biological and pharmacokinetic activity of the new recombinant thrombolytic and anthithrombotic agent RGD SAK-K2-HIR
Szende A.	-	Health-related quality of life in adults with hemophilia: the patient perspective
Szurlej D.	-	Management of refractory postoperative cardiac bleeding with recombinant Factor VIIa (rFVIIa): Cases reported to the hemostasis.com registry
Szutowicz A.	-	Thrombophilic risk factors of ischemic stroke in children
	-	Changes in von Willebrand factor concentration and blood loss during cardiac surgery